The nuclear localization signal of Hepatitis B Virus Core Protein : characterization by expression as EGFP-Core Fusion Protein by Haryanto, Aris
The Nuclear Localization Signal of 
Hepatitis B Virus Core Protein:
Characterization by Expression 
as EGFP-Core Fusion Protein 
INAUGURAL-DISSERTATION
zur Erlangung des Grades eines
Dr. med. vet.
beim Fachbereich Veterinärmedizin
der Justus-Liebig-Universität Giessen
Eingereicht von
Aris Haryanto
Giessen, 2006
 
 
 
The Nuclear Localization Signal of Hepatitis B Virus Core Protein: 
Characterization by Expression as EGFP-Core Fusion Proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INAUGURAL-DISSERTATION 
zur Erlangung des Grades eines  
Dr. med. vet.  
      beim Fachbereich Veterinärmedizin 
der Justus-Liebig-Universität Giessen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aris Haryanto 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gedruckt mit Unterstützung des Deutschen Akademischen Austauschdienstes (DAAD) 
Aus dem Institut für Virologie 
Fachbereich Veterinärmedizin 
der Justus-Liebig-Universität Giessen 
Betreuer: Prof. Dr. Heinz-Jürgen Thiel 
 
 
und 
 
 
dem Institut für Medizinische Virologie 
Fachbereich Medizin 
der Justus-Liebig-Universität Giessen 
Betreuer: Prof. Dr. Michael Kann 
 
 
 
 
 
 
 
 
The Nuclear Localization Signal of Hepatitis B Virus Core Protein: 
Characterization by Expression as EGFP-Core Fusion Proteins 
 
 
 
 
 
 
 
 
INAUGURAL-DISSERTATION 
zur Erlangung des Grades eines  
Dr. med. vet. 
beim Fachbereich Veterinärmedizin 
der Justus-Liebig-Universität Giessen 
 
 
 
 
 
Eingereicht von 
 
Aris Haryanto 
Tierarzt aus Jogjakarta, Indonesien 
 
 
Giessen 2006 
Mit Genehmigung des Fachbereichs Veterinärmedizin 
der Justus-Liebig-Universität Giessen 
 
 
 
 
 
 
 
 
 
 
Dekan:   Prof. Dr. Manfred Reinacher 
 
 
 
 
 
 
 
 
 
Gutachter:  Prof. Dr. Heinz-Jürgen Thiel 
 
Gutachter: Prof. Dr. Michael Kann 
 
 
 
 
Tag der Disputation:       21. Dezember 2005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Erklärung 
 
 
„Ich erkläre: Ich habe die vorgelegte Dissertation selbständig und ohne unerlaubte fremde 
Hilfe und nur mit den Hilfe angefertigt, die ich in der Dissertation angegeben habe. Alle 
Textstellen, die wörtlich oder sinngemäß aus veröffentlichten oder nicht veröffentlichten 
Schriften entnommen sind, und alle Angaben, die auf mündlichen Auskünften beruhen, 
sind als solche kenntlich gemacht. Bei den von mir durchgeführten und in der Dissertation 
erwähnten Untersuchungen habe ich die Gründsätze guter wissenschaftlicher Praxis, wie 
sie in der „Satzung der Justus-Liebig-Universität Giessen zur Sicherung guter 
wissenschaftlicher Praxis“ niedergelegt sind, eingehalten.“ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contents 
 
 
 
1. Introduction            1 
1.1. Nuclear Import of the viral Genome      1 
1.2. Hepatitis B Virus         1 
1.3. Morphology and Structure of HBV        2 
1.4. Classification           4 
1.5. Genome Organisation of HBV       5 
1.6. Life and Replication Cycle of HBV       6 
             2.  HBV Capsid         9 
       3.  Nuclear Import         10 
      3.1. Nuclear Pore Complex (NPC)      12 
      3.2. Nuclear Localization Signal (NLS)      13 
             4.  Nuclear Localization of HBV Core Protein and Capsid      14 
             5.  Presentation of Problem        14 
 
      2.  Materials and Methods        15            
           2.1. Materials          15 
           2.1.1. Antibodies and Beads         15 
           2.1.2. Chemicals         15 
           2.1.3. DNA and Protein Markers         16 
           2.1.4. Enzymes          16 
           2.1.5. Equipments            16 
           2.1.6. Kits          17 
           2.1.7. Synthetic Oliginucleotides        17 
           2.1.8. Solutions and Buffers        18 
           2.1.9. Cell Lines          19 
           2.1.10. Bacteria          20 
           2.1.11. DNA Plasmid Vector         20 
                       a. pUC-991         20 
                       b. pEGFP-C3         20 
                       c. pDsRed2-C1        21 
                       d. pRcCMV-Core          22 
 
          2.2. Methods          23 
          2.2.1. Nuclear Localization of Entire HBV Genome in HuH-7 Cell    23 
                     a. Preparation of Entire HBV Genome     23 
                     b. Preparation of HuH-7       23 
          2.2.2. DNA Plasmid Construction       23 
                     a. pEGFP-Core 1C        23 
         b. pEGFP-Core 2C           24 
         c. pEGFP-Core 3C          25 
         d. pEGFP-Core ∆NLS          25 
         e. pEGFP-Core 1 SV40 NLS       25 
         f.  pEGFP-Core 2 SV40 NLS       25 
         g. pEGFP-Core 3 SV40 NLS       26  
            2.2.3. Ligation           26 
            2.2.4. Transformation           26          
            2.2.5. Minipreparation DNA Plamid Isolation       26 
            2.2.6. Restriction Analysis           27 
2.2.7. Maxipreparation DNA Plasmid Isolation       27 
   2.2.8. Preparation Cell Culture         27 
   2.2.9. Transfection           27 
   2.2.10. Inhibitor Treatment          28 
               a. Staurosporine          28 
               b. Bayer 41-4109          28 
   2.2.11. Indirect Immune Fluorescence        28 
   2.2.12. Immune Fluorescence Confocal Laser Microcopy      29 
   2.2.13. Quantification of the Intracellular Localization      29 
   2.2.14. Quantification of the Cell Division      29 
   2.2.15. Dimerisation Analysis of EGFP-Core 1C Fusion Protein   30 
                a. Preparation of Cell Line and Transfection pEGFP-Core 1C into 
                    HepG2.2.15         30 
                b. Isolation of Lysate from the Transfected Cells    30 
                c. Concentrating of EGFP-Core Fusion Protein    30 
                d. Phosphorylation using 32γATP        30 
                e. Co-immuneprecipitations and their Analysis    31 
                f.  SDS PAGE          31 
                g. Phosphoimager Screening      31 
     
3. Results            33 
         3.1. Nuclear Localizaton of HBV Capsids After Transfection of the Entire HBV  
                Genome into HuH-7 Cells        33 
      .  3.2. Analysis of Fluorescent Marker Proteins      36 
         3.3. Transport Competence of EGFP-Core Fusion Proteins     38 
                 3.3.1. Cloning of pEGFP-Core Fusion Protein     38 
                 3.3.2. Localization of EGFP-Core 1C       41 
        3.4. Localization of EGFP-Core Fusion Proteins with Redundant NLS in 
                 HuH-7 Cells         43 
                 3.4.1. Cloning of EGFP-Core 2C, 3C and ∆C Fusion Protein     43 
                           3.4.1.1. EGFP-Core 2C       43 
                           3.4.1.2. EGFP-Core 3C         44 
                           3.4.1.3. EGFP-Core ∆C         46 
                 3.4.2. Cloning of EGFP-Core 1, 2, 3 SV40 NLS     48 
    3.4.2.1. EGFP-Core 1 SV40 NLS      48 
                           3.4.2.2. EGFP-Core 2 SV40 NLS        50 
                           3.4.2.3. EGFP- Core 3 SV40 NLS      52 
                 3.4.3. Intracellular Localization of pEGFP-Core Fusion Protein and its 
                           Redundants        54 
          3.5. Effect of Staurosporine on the Localization of EGFP-Core 3C and 3 SV40 
                 NLS          56 
          3.6. Effect of FCS on Intracellular Localization of EGFP-Core Fusion Proteins    58 
                 3.6.1. Effect of FCS on Cell Division      58 
                 3.6.2. Effect of Serum on the Localization of EGFP-Core 3 SV40 NLS in  
                           HuH-7 Cells          59 
          3.7. Nuclear Localization of EGFP-Core Fusion Proteins in HepG2 Cells  60 
          3.8. Dimerization of EGFP-Core 1C         63 
          3.9. Effect of the Assembly Inhibitor Bayer 41-4109 on the Localization of EGFP 
                 Core Fusion Proteins          64 
     
4.  Discussion             67 
          4.1. Nuclear Localization of HBV Capsids After Transfection of the Entire 
                 HBV genome into HuH-7 Cells          67 
          4.2. Structure of the Fusion Protein       68 
          4.3. Localization in HuH-7 cells       70 
                 4.3.1. Transport Competence of EGFP-Core Fusion Proteins     70 
     4.3.2. Effect of Cell Cycle and Phosphorylation      71 
          4.4. Localization in HepG2 Cells        72 
          4.5. Molecular Implication for the Nuclear Import and the Viral Life Cycle   73 
 
5. Summary           74 
6. Zusammenfassung         75 
7. References           77 
8. Acknowlegements         84 
9. Appendixes          86 
9.1. List of Figures         86 
9.2. List of Tables         88 
   10.  Curriculum Vitae          89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations 
 
 
aa  amino acids 
ampr  ampicillin resistance 
ATP  adenosine tri phosphate 
bp  base pair 
BSA  bovine serum albumin 
ccc DNA covalently closed circular DNA 
CIP  calf intestinal alkaline phosphatase 
CMV  cytomegalovirus 
DHBV  duck hepatitis B virus 
dNTP  deoxy nucleotide triphosphate 
DMEM  Dulbecco’s modified eagle’s medium 
DR  direct repeat 
E. coli  Escherichia coli 
E-cup  Eppendorf cup 
ECL  enhanced chemiluminescence 
EDTA  ethylendiamine tetra acetic acid 
EGFP  enhanced green fluorescent protein 
EGTA  ethylenglycol tetra acetic acid 
ER  endoplasmic reticulum 
FCS  fetal calf serum 
FG repeat phenylalanine glycine repeat 
Fig  figure 
HBe protein hepatitis B e protein 
HBc protein hepatitis B core protein 
HBs protein hepatitis B surface protein 
HBV  hepatitis B virus 
HHBV  heron hepatitis B virus 
hnRNP heterogeneous nuclear ribonucleoprotein  
kanr/neor kanamycin/neomycin resistance 
kDa  kilo dalton 
LB  Luria broth 
LHBs  large hepatitis B surface protein 
M  marker of DNA/protein 
mab 414  monoclonal antibody 414 
MHBs  middle hepatitis B surface protein 
mRNA  messenger RNA 
NE  nuclear envelope  
NES  nuclear export signal 
NLS  nuclear localisation signal 
NPC  nuclear pore complex 
nup  nucleoporin 
ORF  open reading frame 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
pg RNA pregenomic RNA 
PKC  protein kinase C 
Pol  polymerase 
Pr  priming 
PRE  post transcriptional regulatory element 
Pro  promoter 
rc DNA relaxed circular DNA 
RT  reverse transcriptase 
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SV40 Tag simian virus 40 large T antigen 
SHBs  small hepatitis B surface protein 
TAE  tris acetate EDTA 
TE  tris-EDTA 
°C  degree celsius 
 
 
Introduction 
_________________________________________________________________________ 
1. Introduction 
 
1.1.  Nuclear Import of Viral Genomes 
Many viruses make use of nuclear factors for their multiplication. For nuclear import 
of the viral genome two generally different strategies are described. First, the virus can 
rest in the cytoplasm until the cell undergoes mitosis. When the nuclear envelope 
temporarily dissembles, the viral genome can associate with nuclear factors and thus 
become enclosed in the newly assembling nucleus. Used by most retroviruses, this 
strategy restricts infection to dividing cells. Those viruses however that depend on nuclear 
factors for multiplication and that infect non-dividing cells must deliver their genome 
through the nuclear pore complexes (NPC). This is achieved by making use of the cellular 
transport machinery that facilitates the nuclear import of karyophilic proteins. 
Nucleic acids are not karyophilic per se thus have to be associated in complex with 
karyophilic proteins. In all known cases, the karyophilic proteins are of viral origin and 
either part of the viral capsid (adeno-, herpes- and parvoviruses) or an element of a 
flexible protein-nucleic acid complex (Influenza- and HIV) (reviewed by Whittaker et al., 
2000). Capsids frequently exceed the functional diameter of the nuclear pore that restricts 
karyophilic cargos to a diameter of 39 nm (Panté and Kann, 2002). Only small capsids as 
the one of parvoviruses and the hepatitis B virus (HBV) are small enough to pass the 
NPC. Larger capsids have to disintegrate prior to the import. As it was shown for 
herpesviruses  and adenoviruses, this disintegration may occur at the nuclear pore or as 
shown for influenza virus and the human immunedeficiency virus. The flexible karyophilic 
structure comprising the genome may be already released in the cytoplasm. 
 
 
1.2. Hepatitis B Virus 
The Hepatitis B virus (HBV) is a small enveloped DNA virus that is composed of 
an outer envelope and an inner nucleocapsid. The nucleocapsid also termed core particle 
or capsid consists of a single protein species called core protein. The majority of capsids 
have a T=4 symmetry and a diameter of 36 nm, while the minority has a T=3 symmetry 
and a diameter of 32 nm (Crowther et al., 1994; Kenney et al., 1995). A functional 
difference is not known. Within the lumen of the capsid the 3.2 kb-long circular, partially 
double stranded viral DNA genome in enclosed. The HBV encodes for four partially 
overlapping open reading frames. 
 HBV is the prototype member of the hepadnavirus family that belongs to the 
pararetroviruses. They share a characteristic replication strategy, which includes a 
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multiplication of genomic information via an RNA intermediate. Within the capsid the RNA 
intermediate is converted into single stranded DNA of minus strand polarity. 
Concomitantly, the RNA in the resulting DNA-RNA hybrid is degraded by an RNase H 
acivity. The minus DNA strand is used as template for synthesis of the incomplete plus 
strand DNA. This genome maturation is mediated by the viral polymerase that comprises 
an RNase H-, RNA- and a DNA-dependent DNA polymerase activity. Due to the priming 
reaction of minus strand synthesis during which the tyrosine residue 67 of the polymerase 
serves as the acceptor for the first nucleotide, the polymerase becomes covalently linked 
to the minus strand DNA. In contrast to the orthoretroviruses, this genome maturation 
takes place within the capsids prior to secretion. 
Upon infection of a new cell the resulting relaxed circular DNA form (rcDNA) of the 
virus becomes converted into a covalently closed circular DNA (cccDNA) within the 
nucleus. This process requires not only the repair of the single stranded region and 
ligation of the DNA ends but the removal of the polymerase and a short triple-stranded 
region. The cccDNA is used as an intranuclear template for RNA transcription including 
the RNA pregenome that encodes the viral polymerase and the core protein (reviewed by 
Jilbert  and Mason, 2002).  
 
 
1.3. Morphology and Structure of HBV 
After negative staining and visualization by electron microscopy, HBV appears as 
double-shelled particle of 42 nm in diameter. The surface of the HBV virions consists of 
around 240 surface proteins of 3 different membrane-spanning polypeptides: The large 
(L), middle (M) and small (S) surface (HBs) protein. The HBs proteins are co-terminally 
with their carboxy end and differ in additional amino terminal domains. The LHBs consists 
of an S domain and a pre S1 plus pre S2 domain (Heermann et al., 1984). The preS1 
domain of LHBs can be localized externally or internally (Bruss et al., 1994; Lambert and 
Prange, 2003). The MHBs contains only the preS2 and S domain, and the SHBs consists 
of only of the S domain. In infected hepatocytes, only a minority of the surface proteins is 
part of the virion but the majority is secreted as subviral particles (SVPs). Dependent upon 
the composition of the 3 surface proteins SVPs either form filaments or spheres of 20 nm. 
A schematic presentation of virus and SVPs is given in Figure 1.  
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Figure 1. Schematic presentation of HBV and subviral particles.  A: Virion. B: 20 nm particles. 
C: Filaments. The surface proteins are drawn in red. PreS1: Light red, preS2: Middle red, S: Dark 
red. The putative hsc70 bound to the preS1 is depicted in blue. The viral capsid forms the inner 
shell of the virion. Its core protein shown in black. Within the lumen the partially double stranded 
DNA is found (minus DNA strand: Blue line, plus DNA strand: Red line. The polymerase is drawn in 
green with a separated priming domain (Pr) in light green. The polymerase-bound heat shock 
proteins are not depicted. Figure from Kann and Gerlich (1997). 
 
 
 The surface proteins of the virus and SVP are assembled at the endoplasmic 
reticulum (ER) and bud into the lumen of post-ER intermediate compartment. Thus the 
lipids in the outer protein shell or the HBs particles are derived from an intracellular 
compartment and not from the plasma membrane. 
Within virions the surface proteins enclose the capsid. The envelopment is mediated 
by an interaction of the core particle with the internally localized preS1 domain of LHBs 
(Bruss, 1997; Ponsel and Bruss, 2003). The envelopment requires DNA synthesis within 
the capsid (Gerelsaikhan et al., 1996) implying that the genome maturation induces a 
structural change of the capsid surface. 
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1.4. Classification 
The molecular and biological similarity of HBV led to define the family of 
Hepadnaviridae (from Hepa = liver and DNA for the type of genome) (Howard, 1995). The 
mammalian viruses are called genus Orthohepadnavirus (e.g. HBV, WHV, GSHV). 
Because of significant structural differences the avian viruses form the separate genus 
Avihepadnavirus (e.g. DHBV, HHBV). For more details see Table 1. 
 
Table 1. Members of family Hepadnaviridae and their hosts   
Genus Spesies and Strains Host 
  Hepatitis B Virus  Human 
  HBV, Dane et al., 1970 (Homo sapiens sapiens) 
  Woodchuck Hepatitis Virus Woodchuck 
  WHV, Summer et al., 1978 (Marmota monax) 
 Orthohepadnavirus Ground Squirrel Hepatitis Virus Ground Squirrel 
  GSHV, marion et al., 1980 (Spermophylus beecheyi) 
  Woolly Monkey Hepatitis B Virus Woolly Monkey 
  WMHBV, Lanford et al., 1998 (Lagothrix lagotricha) 
  Arctic Ground Squirrel Hepatitis Virus Arctic Ground Squirrel 
  ASHV, Testut et al., 1996     (Spermophylusparryi kennicotti)
  (tentative spesies)   
  Duck Hepatitis B Virus Peking Duck 
  DHBV, Mason et al., 1980 (Anas domesticus) 
  Heron Hepatitis Virus Heron 
  HHBV, Feitelson et al., 1986 (Adrea cinerea) 
  Storck Hepatitis B Virus White Storck 
  STHBV, Pult et al., 1998 (Ciconia ciconia) 
 Avihepadnavirus Snow Goose Hepatitis B Virus Snow Goose 
  SGHBV, Chang et al, 1998 (Anser caerulescens) 
  Grey Teal Hepatitis B Virus Grey Teal Duck 
  GTHBV, Li et al 1998 (Anasgibberfrons gracilis) 
  Maned Duck Hepatitis B Virus Maned Duck 
  MDHBV, Li et al., 1998 (Chenonetta jubata) 
  Ross Goose Hepatitis Virus Ross Goose 
  RGHV, Testut et al., 1996 (Anser rossi) 
  (unassigned virus in the family)   
 
Although containing a DNA genome thus differing from the RNA-containing 
Retroviridae, the common strategy of reverse transcription places them and the 
Caulimoviridae of plants into one related group of viruses called pararetroviruses (Toh et 
al., 1983).  
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1.5. Genome Organization of HBV  
In the virion, the genome is circular and partially double stranded (Robinson et al., 
1974). The genome is approximately 3200 nucleotides in length (Fauquet et al., 2005).  
The numbering of base pairs of the HBV genome is based on the cleavage site for the 
restriction enzyme Eco RI or at homologous sites, if the Eco RI site is absent. An 
alternative numbering, beginning with the first base of the precore start codon, is also 
used. There are at least seven subtypes of HBV, distinguished by sequence differences in 
the surface antigen gene.  
 Mammalian hepadnaviruses contain four overlapping open reading frames (ORFs). 
They encode seven different hepatitis B proteins (see Fig. 2) via transcription of five 
mRNAs. Every base pair in the HBV genome encodes at least one of the HBV proteins 
and eventually overlaps with regulatory elements for transcription, the site of 
polyadenylation, the encapsidation signal of the RNA pregenome (ε) and structural 
elements required for circularization of the minus strand DNA. 
There two classes of mRNAs: Two of supergenomic and three of subgenomic 
length. All mRNA use a common polyadenylation signal and become exported into the 
cytoplasm without splicing. The longest mRNA comprises the start codon of the pre 
core/core ORF. Translation from this AUG generates a primary translation product that 
includes the precore sequence. The precore sequence leads to translocation into the ER 
where the signal peptide is cleaved partially. Then in the Golgi compartment the carboxy 
terminus is removed by proteases, which leads to secretion as a ~18 kDa protein called 
the HBeAg.  
On the 34 bases shorter mRNA that serves as the RNA pregenome, the precore 
AUG is not present so that translation starts with 5' located start codon allowing synthesis 
of the core protein. The viral polymerase is encoded on a down stream located 
overlapping ORF. The initiation of polymerase translation - either by ribosomal frame shift 
or by internal initiation - is controversially discussed. 
The longest subgenomic mRNA comprises the in-frame located ORFs of preS1, 
preS2 and S, encoding LHBs. Most abundant in infected cells is a shorter mRNA that 
encloses the start codons of the preS2 and the S ORF. However, in the majority of 
translation events not the first but the third AUG is used so that the S protein is 
overexpressed. The shortest mRNA encodes the HBx protein. The precise function of this 
translation product is unclear. It is transactivating numerous promoters and is essential for 
establishment of in vivo infection, as determined in the woodchuck using the WHV (Zoulim 
and Seeger, 1994). Furthermore, it is assumed that it is involved in the development of 
liver cell carcinoma (Tennant et al., 2004). 
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Figure 2.  Genome organisation of HBV. The HBV genome as it is found in mature viruses is 
shown in the center with a negative DNA strand and incomplete positive strand. The positions of 
the direct repeats 1 (DR1) and 2 (DR2) are depicted at the beginning of the RNA primer for plus 
DNA strand synthesis. The primer domain of the viral polymerase is covalently linked to the 5' end 
of the minus DNA strand. The catalytic domains of the polymerase are drawn as a separated 
protein.  The ORFs and their relative position on the genome with corresponding start and 
termination sites are shown outwards of the genome. The transcribed HBV RNAs are show in the 
outer region. The black triangles represent the different 5’ ends of the RNAs. The common 3’ end is 
located at position 1921, followed by a 300 nucleotides of poly (A) sequence. The encapsidaton 
signal ε is drawn as a dotted box. The numbering follows the isolate 991. Figure modified from 
Kann and Gerlich (2005).  
 
 
1.6. Life and Replication Cycle of HBV 
HBV must first attach to a cell capable of supporting its replication. The liver is the 
most effective cell type for replicating HBV, though the other extrahepatic sites have been 
found to be able to support the replication to some extent. Viral attachment often 
determines host and tissue specificity of a virus. However for HBV, the receptor(s) remain 
unclear. Consequently, the initial steps of HBV entry are poorly understood. Several 
differentiated and immortalized cell lines are capable of supporting viral replication if 
transfected with viral DNA (Sureau et al., 1986; Chang et al., 1987; Sells et al., 1987). 
Viral uncoating does not require acidification in an endocytotic vesicle (Kock et al., 
1996) and results in a released cytoplasmic nucleocapsid. The capsid is transported 
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through the nuclear membrane into the nuclear basket (Kann et al., 1999; Rabe et al., 
2003). There the genome becomes released into the karyoplasm where the rc-form of the 
genome is repaired generating the cccDNA form of the viral genome. Unlike the 
Retroviridae, integration of HBV DNA into host cell DNA is not required for replication. In 
fact, integration of HBV DNA results in the disruption of one or more HBV ORFs and 
prevents transcription of functional pre genomic RNA (pgRNA). Once recircularized, 
enhancer and promoter allow transcription of the various HBV transcripts. 
For the intracellular life cycle the pregenomic mRNA is most important. As the other 
mRNAs it becomes exported into the cytoplasm without being spliced. This unusual export 
is caused by the presence of the so-called post regulatory element (PRE) that is present 
on all HBV mRNAs (Zang and Yen, 1999). Its molecular mechanism is not fully 
understood. After synthesis of the polymerase, this enzyme binds to the ε-signal at the 5' 
end of this RNA being a prerequisite for specific encapsidation of this RNA into the capsid 
(Hirsch et al., 1990; Pollack et al., 1994), most likely by an interaction of the polymerase 
with the core proteins (Lanford et al., 1999). 
DNA synthesis is initiated at a bulge region within ε during which the first 
deoxynucleotide becomes linked to Tyr63 of the polymerase (Tang and McLachlan, 
2002). After synthesis of the first 3 nucleotides the complex of nucleotides and 
polymerase translocates to a DR1 (direct repeat 1) termed region closed to the 3' end of 
the pregenome. From there reverse transcription proceeds to the 5' end, being combined 
with the degradation of the RNA by an RNaseH activity of the polymerase. This activity 
leaves an oligonucleotide of ~18 bases undegraded, which translocates to a 
complementary region on the minus strand DNA (DR2). At this site the polymerase 
continues with plus strand DNA synthesis that spans the 3' and 5' end of the minus 
stranded DNA leading to circularization of the genome (reviewed by Kann and Gerlich, 
2005). 
Ongoing genome maturation only occurs after the polymerase is encapsidated.  
Consequently, the polymerase in the absence of the core proteins copies only a few 
nucleotides on its natural template (Gerelsaikhan et al., 1996). It must be thus concluded 
that a premature release of a replication intermediate leads to disruption of the viral life 
cycle. However, in vivo one to 10 HBV are sufficient to cause HBV infection in 
chimpanzees (Ulrich et al., 1989) making it most likely that the genome release is highly 
coordinated. Accordingly, only capsids containing a mature genome release it into the 
karyoplasm as determined in digitonin-permeabilized cells (Rabe et al., 2003). 
The mature capsids have two possible fates: Early in infection the capsids direct the 
progeny viral DNA into the nucleus of the already infected cell. This leads to amplification 
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of the viral cccDNA to approx. 10-20 copies. Later in infection when sufficient amounts of 
surface proteins are synthesized, the mature capsids become enveloped by the surface 
proteins leading to secretion of progeny HBV. 
 
 
Figure 3.   Schematic drawing of the HBV life cycle. The attachment and entry of HBV into the 
cytoplasm is not unequivocally identified. According to most publications HBV enters the cell by 
endocytosis, followed by a pH-independent release of the capsid into the cytosol. The capsid binds 
to the nuclear pore (NPC) mediated by importin α and ß and is transported into the nuclear basket. 
There the DNA genome is released into the karyoplasm where repair and generation of the 
covalently closed circular DNA (cccDNA) occurs. This DNA serves as the template for transcription 
of the mRNAs. For genome replication, one mRNA spesies of supergenomic length is used and 
translated into core protein and - from an overlapping reading frame into the viral polymerase. 
Polymerase, cellular heat shock proteins (not shown) and RNA interact. This complex is specifically 
encapsidated by the core protein into particles (immature capsid). Within core particles the 
encapsidated RNA serve as the template for reverse transcription followed by second strand DNA 
synthesis (genome maturation). The core particle containing mature DNA genome can be either 
enveloped into the surface proteins (red blocks) and secreted as mature virus or can be 
transported to the nucleus following the import pathway during the initial infection.  Figure modified 
from Kann and Gerlich (2005). 
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2. HBV Capsid 
The core particles are involved in a number of important steps in the replication 
cycle of HBV, such as RNA packaging, DNA synthesis, recognition of viral envelope 
proteins and transport of the genome to and into the nucleus. Consequently, the 21.5 kDa 
capsid protein can be detected in the cytoplasm (Ou et al., 1986), nucleus (Mc Lachlan et 
al., 1987)  or both (Chu and Liaw, 1987; Sureau et al., 1986) within infected hepatocytes . 
Its N terminal 144 amino acid residues form 5 α-helices and direct the assembly of the 
capsid particle (Gallina et al., 1989; Hatton et al., 1992). In contrast, the carboxyl terminus 
from residue 150 to 185 (HBV subtype adw) or 183 (ayw), is dispensable for particle 
assembly but mediates interactions between the capsid protein and the nucleic acid. This 
region contains four clusters of arginine residues (see Fig. 4) overlapping with up to seven 
serine residues (number depends upon the genotype) that are potential target sites for the 
protein kinase that is enclosed during capsid assembly. The first cluster of arginine 
residues is required for binding of viral DNA (Hatton et al., 1992; Nassal, 1992; Yu and 
Summers, 1991). 
 
 
Figure 4.  Primary amino acid sequence of HBV capsid protein. HBV capsid protein consists of 
183 to 185 amino acids. The nuclear localization signal is located at the C terminus. It contains 
fours clusters of arginine residues and three overlapping SPRRR motifs. P indicates potential 
phosphorylation sites at serine residues. 
 
After synthesis in the cytoplasm the core molecules form dimers (Zhou and 
Standring, 1992) that trimerize (Zlotnick et al., 1999). The resulting hexamers assemble to 
capsids. This assembly occurs spontaneously and is independent upon other viral 
proteins. In vivo a complex of pregenome, polymerase and the heat shock proteins Hsp40 
and Hsc70 are encapsidated (Bartenschlager et al., 1990; Hirsch et al. 1990, Beck and 
Nassal 1998) while in the absence of the polymerase cellular RNA is encapsidated 
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unspecifically. Furthermore a cellular protein kinase becomes encapsidated that 
phosphorylates the serine residues between the arginine clusters to an unknown extent. 
After released from the reducing environment in the cytoplasm the core protein dimers 
become linked by disulphide bridges (Jeng et al., 1991). The capsids do not form a closed 
shell but contain 2 nm holes that allow diffusion of nucleotides and ATP into the lumen. 
They show spikes on their surface which have been successfully used as a carrier site for 
foreign epitopes in a highly immunogenic conformation (Pumpens and Grens, 2001). 
Although capsid formation does not require any other viral component, the presence of 
RNA strongly enhances the assembly (Seifer and Standring, 1995). This phenomenon is 
caused by stabilizing interaction of RNA and the arginine clusters. Consequently, 
truncated core proteins which are lacking NLS of the carboxy terminus show much slower 
assembly kinetics and are less stable than the wild type. The localization of carboxy 
terminus is however flexible. They are internally localized in RNA-containing core particles 
(Zlotnick et al., 1997) but genome maturation results in an exposure NLS on capsids 
surface (Rabe et al., 2003) presumably because of a weaker interaction to double-
stranded DNA than to RNA. Whether this structural change is required for the interaction 
with the preS1 is not known. 
 
  
3.  Nuclear Import 
The nucleus and cytoplasm are separated by the double membrane of the nuclear 
envelope. The outer membrane is continuously connected with the membrane of the 
endoplasmic reticulum. Transport between the cytoplasm and the nucleoplasm is highly 
regulated and occurs through protein-lined aqueous channels called nuclear pore 
complexes (NPC). This transport is facilitated by soluble transport receptors.  
The best study receptors belong to the importin ß superfamily. While importin ß can 
directly bind to a karyophilic cargo if it exposes an importin ß binding domain (IBB) the 
indirect binding via the adapter protein importin α to a nuclear localization signal (NLS) 
seems to be the most abundant pathway. Both, IBB and NLS consist of multiple basic 
amino acids. 
A second member of the importin ß superfamily is transportin that binds directly to 
the cargo via a leucine-rich M9 domain as it is found on protein A1 of the hnRNP complex. 
Further not as well characterized transport receptors comprise the proteins NTF2, 
Importin 5, RanBP6, Importin 7 and Transportin SR (reviewed by Fried and Kutay, 2003). 
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Figure 5. Pathway of the nuclear import cycle. 1) Importin α binds to the NLS of a karyophilic 
cargo followed by Importin ß binding to the complex. 2) Importin β mediates contact with NPC and 
the import of cargo/importinα/importin β complex from the cytoplasmic to the nuclear side of NPC. 
3) Nuclear import is terminated by binding of RanGTP to importin β, which releases the complex 
from the NPC. 4) The importin β-RanGTP complex can directly exit from the nucleus. 5) Importin α 
releases karyophilic cargo. 6) Importin α binds to CAS and RanGTP for its re-export. 7) Importin 
α/CAS/RanGTP complex is exported to the cytoplasm through the NPC. 8) In the cytoplasm, 
Importin α/CAS/RanGTP complex is disassembled by hydrolysis of GTP to GDP. This reaction is 
catalysed by RanGAP and supported by RanBP1. 9) Importin α is released from Importin 
α/CAS/RanGTP complex. 10) Similarly, importin  β is disassembled. Importin α and β can 
recombine for the next round of another cargo protein. Figure adapted from Görlich and Kutay 
(1999). 
 
After formation of a cargo-import receptor complex, the transportin or importin β 
mediates binding to the cytosolic face of the NPC and subsequent transport through the 
nuclear pore into nuclear basket (Fig. 5). The molecular details of the passage through the 
nuclear pore, either active or by an "allowed diffusion" are still not fully known. Within the 
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basket, which is a cage-like structure formed by eight fibers derived from the karyoplasmic 
face of the NPC, the import complex becomes arrested. The import reaction is terminated 
by the interaction of transportin or importin with Ran in its GTP bound form (RanGTP). 
While the cargo diffuses deeper into the karyoplasm, the transport receptors become 
exported into the cytoplasm using NTF2 (Moore and Blobel, 1994; Paschal and Gerace, 
1995). There, Ran-bound GTP is hydrolyzed to GDP. RanGDP shows however only a 
weak affinity to importins and transportin so that the receptors become released and can 
facilitate a new import reaction. The released RanGDP is imported into the karyoplasm by 
NTF2, followed by an exchange of GDP by GTP, catalyzed by the chromatin-bound 
protein RCC1. It is assumed the receptors participate in several hundred rounds of import. 
 
 
3.1. Nuclear Pore Complex (NPC)   
In vertebrates, the nuclear pore complex is an 8 fold-symmetric protein complex with 
a molecular mass of 125 MDa. It contains about 30 different proteins that are present in at 
least 8 fold redundancies. The NPC consists of a membrane-embedded framework (the 
spoke complex), which is formed by eight multidomain spokes with two rings on each face 
(Fig. 6). The ring facing the cytoplasm is decorated with eight 50 nm fibrils extending into 
the cytoplasm and the nuclear ring is capped with a basket-like assembly of eight thin, 50-
100 nm filaments joined distally by a 30-40 nm diameter terminal ring. The center of the 
channel harbors a hydophobic framework through which the signal-mediated bi-directional 
transport of macromolecules occurs. The proteins that form the NPC are called 
nucleoporins (nups). Nups have been localized to discrete regions of the NPC and are 
often used as markers for this compartment. Approximately half of the nucleoporins 
contain a phenylalanine-glycine repeat motif (FG repeat) which play an important role in 
the nuclear transport of protein. Structure and function of the NPC is reviewed by 
Izaurralde et al. (1999). 
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Figure 6. Model of nuclear pore complex. The major components include the basic framework, 
the gated channel, the cytoplasmic and nuclear rings, and the cytoplasmic fibrils and the nuclear 
basket. The structure in the lumen of the pore depicts an import complex in transit. Figure adapted 
from Izaurralde et al., (1999). 
 
 
3.2. Nuclear Localization Signal (NLS) 
Facilitated transport into and out of the nucleus is determined by specific sequence 
motifs that constitute localization signals. For import, these are called nuclear localization 
sequences (NLSs), and for export, nuclear export signal (NESs). They can confer nuclear 
transport competence to proteins restricted to the cytoplasm or the nucleus. 
The first NLS to be identified was a short stretch of basic amino acids (PKKKRKV) in 
simian virus 40 (SV40) large T antigen (Kalderon et al., 1984). Similar sequences were 
subsequently found in numerous viral and cellular proteins with karyophilic properties. 
Other versions of this motif display a bipartite sequence, e.g. in nucleoplasmin 
(KRPAATKAAGQAKKK) (Robbins et al., 1991). As they were the first to be discovered, 
these import signals are called as classical NLSs. As determined by co-crystalization of 
importin α with NLS-peptides (Fontes, 2000), a lysine residue appears to be essential for 
the interaction. 
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4. Nuclear Localization of HBV Core Protein and Capsid 
In histology of HBV infected human livers capsids mainly show a nuclear localization 
(Gudat et al. 1975, Furuta et al., 1975). This distribution is intrinsic for the HBV core 
protein since identical staining is found in HBV transgenic mice (Guidotti et al., 1994). In 
transfected cells nuclear localization is enhanced during G0/G phase but suppressed 
during the S phase (Yeh et al., 1993). Since hepatocytes in the liver are resting cells the 
latter observation is in accordance with the data obtained from histology. 
The NLS of HBV core is located within the carboxy-terminus between amino acids 
158 and 168 (158-PRRRTPSPRRR-168). Noteworthy, the capsid NLS does not comprise 
a lysine residue so that it must be speculated that the NLS shows only a weak interaction 
to importin α. Nonetheless, other NLS without lysine residues , as the Borna disease virus 
p10 protein, were identified in that additional the NLS flanking sequences were required 
(Wolff et al., 2002). However, at least in assembled capsids the redundancy of exposed 
NLS may compensate a poor binding affinity. 
Phosphorylation of the core proteins within the context of the capsid was shown to 
be a prerequisite for the importin α/ß-mediated interaction of the particle with NPC (Kann 
et al., 1999). However, using protein conjugates with the HBV capsid NLS is was shown 
that the phosphorylation of the serine residue that is localized within NLS inhibits its 
functionality (Vlachou, PhD thesis 1999). These different observations may be interpreted 
that the phosphorylation occurs outside the NLS and is only responsible for the structural 
change that leads to the external exposure of the NLS. A similar phenomenon was 
observed for the SV40 Tag in which phosphorylation at a site directly adjacent to the NLS 
inhibits the NLS function (Jans and Jans, 1994), while further upstream phosphorylation 
enhances the NLS transport competence ( Hübner et al., 1997).  
 
 
5. Presentation of the Problem 
Although being essential for the viral life cycle, the molecular details of the nuclear 
transport of the HBV core protein and capsid are only partially known. The understanding 
of the NLS - nuclear transport receptor interaction is mainly based on observations using 
biochemical assays as co-immune precipitations and in vitro transport assays. This work 
shall give corresponding in vivo evidence. By expressing fusion proteins of core and a 
marker protein, the strength of the capsid NLS shall be investigated. 
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2.  Materials and Methods 
2.1. Materials 
2.1.1. Antibodies and Beads 
Goat anti mouse antibody, Texas Red conjugated  DIANOVA, Hamburg 
Goat anti rabbit antibody, FITC conjugated   DIANOVA, Hamburg 
Mouse anti nuclear pores  complex antibody (mAb 414) BabCo, Freiburg 
Rabbit anti EGFP antibody     CLONETECH, USA 
Rabbit anti hepatitis B core antibody (Dako)  DakoCytomation, Hamburg 
Dynabeads M-280, Sheep anti rabbit IgG    DYNAL, Hamburg 
Dynabeads M-280, Sheep anti mouse IgG   DYNAL, Hamburg 
    
2.1.2. Chemicals 
Adenosintriphosphat      BOEHRINGER, Mannheim 
Agarose (SEAKEM)       BOEHRINGER, Mannheim 
Bayer 41-4109      BAYER, Leverkusen 
ß-Mercaptoethanol      ROTH, Karlsruhe 
Bromphenolblau      SIGMA, Deisenhofen 
BSA (Bovine Serum Albumin)    ROTH, Karlsruhe  
Coomasie brilliant blue R 250    MERCK, Darmstadt 
Collagen       SIGMA, Deisenhofen 
Creatinine phosphate      SIGMA, Deisenhofen 
DABCO       SIGMA, Deisenhofen 
Dithiothreitol (DTT)      SIGMA, Deisenhofen 
dNTP        BOEHRINGER, Mannheim 
EDTA        SIGMA, Deisenhofen 
EGTA        SIGMA, Deisenhofen 
Ethidium bromide      SERVA, Heidelberg 
FITC-BSA       SIGMA, Deisenhofen 
Fetal Calf Serum (FCS)     GIBCO-BRL, Karlsruhe 
32γ ATP         AMERSH. PHARMA., Freiburg 
Glyserin        MERCK, Damstadt 
Goat serum       DIANOVA, Hamburg 
Microsome       ROCHE, Mannheim 
MOVIOL       HOECHST, Frankfurt 
Nonindet P-40 (NP-40)     FLUKA, Buchs 
Nupage Bis-Tris gel (4-12%)     INVITROGEN, Karlsruhe 
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Phenol        ROTH, Karlsruhe 
Protease inhibitor      ROCHE, Mannheim 
Staurosporine       SIGMA, Deisenhofen 
Tfx-20 Transfection agents      PROMEGA, Mannheim 
Tris-Base       ROTH, Karlsruhe 
Triton x-100       SERVA, Heidelberg 
Trypsine       GIBCO-BRL, Karlsruhe 
 
2.1.3. DNA  and Protein Markers 
1 Kb plus DNA ladder     GIBCO-BRL, Karslruhe 
14C Methylated protein marker    AMERSH. PHARMA., Freiburg 
 
2.1.4. Enzymes 
CIP (Calf Intestinal Alkaline Phosphatase)   NEW ENG. BIOLAB, Frankfurt 
Creatininphosphokinase (10 Unit/µl)    SIGMA, Deisenhofen 
DNase I (10 Unit/µl)      ROCHE, Mannheim 
Restriction endonucleases: Apa I, Ava I, Bgl II  NEW ENG. BIOLAB, Frankfurt 
    Bsp EI, Bsp MI,  
    Hind III, Eco RI 
Proteinase K       BOEHRINGER, Mannheim 
RNase A (1 Unit/µl)      ROCHE, Mannheim 
SDS (Sodium Duodecyl Sulfat)    MERCK, Darmstadt 
S7 nuclease       ROCHE, Mannheim 
T4 DNA ligase       NEW ENG. BIOLAB, Frankfurt 
T4 polynucleotide kinase     NEW ENG. BIOLAB, Frankfurt 
T4 DNA polymerase      NEW ENG. BIOLAB, Frankfurt 
 
2.1.5. Equipments 
Binocular microscope      LEITZ, Wetzlar 
Centrifuge BIOFUGE 15 R     HERAEUS, Hanau 
Confocal laser scan  microscope    LEICA Lasertech., Heidelberg 
Desk Centrifuge 5415 C     EPPENDORF, Hamburg 
Films for autoradiography     AMERSH. PHARMA., Freiburg 
Nanosep  3K, 10K       PALL FILTRON, USA 
Petri dishes       GREINER, USA 
Rotors for ultracentrifuge     BECKMAN, München 
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Typhoon 9200      AMERSH. PHARMA., Freiburg 
Ultracenfrifuge L5-50      BECKMANN, München 
Ultrasonic sonicator UW-70     BENDELIN ELECTRO., Berlin 
UV spectrophotometer Du-70    BECKMAN, München 
24  and 96 well dishes     NUNC INC., USA 
 
2.1.6. Kits 
BSA Assay kit       UPTIMA, Frances  
Gel extraction kit      QIAGEN, Hilden 
Maxipreparation plasmid purification kit   QIAGEN, Hilden 
 
2.1.7. Synthetic Oligonucleotides  
Synthetic oligonucleotides were purchased from firma MWG-Biotech. The nucleotide 
sequences are: 
 
2C  sense (78 nucleotides): 
5’-CTC GGG AAT CTC AAT GTC CTA GAA GAA GAA CTC CCT CGC CTC GCA GAC 
GAT CTC AAT CGC CGC CGC GTC GCT AGG GCC-3’ 
 
2C  antisense (69 nucleotides): 
5’-CTA GCG ACG CGG CGA TTG AGA TCT GCG TCT GCG AGG CGA GGG AGT TCT 
TCT TCT AGG ACA TTG AGA TTC-3’. 
 
3C sense (129 nucleotides): 
5’-CTC GGG AAT CTC AAC CTA GAA GAA GAA CTC CCT CGC CTC GCA GAC GCA 
GAT CTC AAT CGC CGC GTC GCC CTA GAA GAA GAA CTC CCT CGC CTC GCA 
GAC GCA GAT CTC AAT CGC CGC GTC GCT AGG GCC-3’ 
 
3C antisense (123 nucleotides):  
5’-CTA GCG ACG CGG CGA TTG AGA TCT GCG TCT GCG AGGCGA GGG AGT TCT 
TCT TCT AGG GCG ACG CGG CGA TTG AGA TCT GCG TCT GCG AGG CGA GGG 
AGT TCT TCT TCT AGG ACA TTG AGA TTC-3’. 
 
1 SV40 NLS sense (47 nucleotides): 
5’-CCG GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG TAG GGG CC-3’ 
 
1 SV40 NLS antisense (39 nucleotides): 
5’-C CTA CAC CTT TCT CTT CTT CTT AGG AAC AAC AGT AGT TT-3’  
 
2 SV40 NLS sense (68 nucleotides):  
5’-CCG GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG CCT AAG AAG 
AAG AGA AAG GTG TAG GGG CC-3’ 
 
2 SV40 NLS antisense (60 nucleotides):  
5’- C CTA CAC CTT TCT CTT CTT CTT AGG CAC CTT TCT CTT CTT CTT AGG AAC 
AAC AGT AGT TT-3’ 
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3 SV40 NLS sense (92 nucleotides): 
5’-CCG GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG CCT AAG AAG 
AAG AGA AAG GTG CCT AAG AAG AAG AAG AGA AAG GTG TAG GGG CC-3’ 
 
3 SV40 NLS antisense (81 nucleotides) 
5’ C CTA CAC CTT TCT CTT CTT CTT AGG CAC CTT TCT CTT CTT CTT AGG CAC 
CTT TCT CTT CTT CTT AGG AAC AAC AGT AGT TT-3’ 
 
2.1.8. Solutions and Buffers 
Agarose running buffer (TAE pH 7.8)       40 mM Tris-Acetat (ROTH, Karlsruhe) 
               1 mM EDTA (SIGMA, Deisenhofen) 
 
Coomasie destaining solution            20 % Methanol 
                5 % Essigsäure 
 
Coomasie staining solution    0.1 % (w/v) Coomasie brilliant blue 
      7.5 % Essigsäure 
      50 % Methanol 
 
Moviol      2.4 g Moviol (HOECHST, Frankfurt) in 
      6.0 g in Glycerin, 
      12 ml 200 mM Tris-Buffer pH 8.5 
stored at - 20ºC. 
 
PAGE running buffer 10 X 250 mM Tris-HCl (pH 8.3)  (ROTH, Karlsruhe) 
      1920 mM Glycin  (ROTH, Karlsruhe) 
      1 %  SDS (MERCK, Damstadt) 
 
PBS (pH 7.4)     171 mM NaCl (ROTH, Karlsruhe) 
       3.4 mM KCl 
        10 mM  Na2HPO4 
       1.9 mM KH2PO4 
 
TAE buffer (pH 7.8)  40 mM Tris-Acetat (pH 7.8)  (ROTH, Karlsruhe) 
    1 mM EDTA (pH 8.0) (SIGMA, Deisenhofen) 
 
Tris-EDTA  10 mM Tris-HCl (pH 7.5) (ROTH, Karlsruhe) 
    1 mM EDTA (pH 8.0) (SIGMA, Deisenhofen) 
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LB medium  10 g       Bacto Tryptone   (DIFCO Labor.,USA) 
  10 g       Yeast Extract  (DIFCO Labor., USA) 
    5 g       NaCl   (ROTH, Karlsruhe) 
  ad   1 L       dH2O  
           autoclaved before used   
 
LB/Ampicilin agar dishes LB- liquid medium was added to bacto agar at 15 
g/L. After being autoclaved the medium was cooled 
to 50°C before Ampicillin was added to a final 
concentration of 100 µg/ml. 15 ml aliquots were 
given in 10 cm culture dishes for bacteria. The 
dishes were stored at 4°C. 
 
LB/Kanamycin agar dishes The dishes were prepared as described above but 
Kanamycin in a concentration was added to a 
concentration of 30 µg/ml instead of the Ampicillin. 
 
DMEM high glucose The desiccated powder was dissolved with H20 to a 
volume of 9 liter. 3.7 g/L  NaHCO3 were added and 
the pH was adjusted to 7.0 by CO2 before the 
medium was sterilized by filtration and storage at 
4°C. FCS in the required concentration was added to 
500 mL of medium. 
 
Medium for storage of cells  60 %            DMEM High Glucose 
     20 %            FCS (PANSYSTEMS, Aidenbach) 
     20 %            DMSO (MERCK, Darmstadt) 
 
2.1.9. Cell Lines 
HepG2    Human immortalized hepatoblastoma  cell line 
HepG2.2.15.    Human immortalized hepatoblastoma cell line, which 
     is  stable  transfected with the HBV genome  (Sells et 
al., 1987). The cells secrete infectious HBV.   
HuH-7     Human  Hepatoma  cell  line,  established  from a  
     hepatocellular carcinoma  of  57  year old Japanese.  
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2.1.10. Bacteria  
E. coli strain XL-1 Blue  rec A-, lac-, end A1,gyr A96, thi, hsd R17, sup E44, 
                                                           rel A1 (F’, pro AB, lacIq, lacZ, M 15, Tn10  (Bullock  
                                                           et al. 1987) 
     
2.1.11. DNA  Plasmid Vector 
            a. pUC-991 
 
 
   
  pUC-991
(5.907 bp)
 HBV 991
 genome
amp
1
396
Eco RI
Eco RI
 
 
 
Figure 7.  Schematic drawing of pUC-991 vector. pUC-991 derived from pUC19 (2686 
bp). The entire HBV genome from isolate 991 (3221 bp) was subcloned into the 
multicloning site  by  Eco RI restriction site. The vector backbone contains ampicillin 
resistance gene (Ampr ).  
 
 
b. pEGFP-C3 (CLONETECH) 
 
    
 
Figure 8. Schematic drawing of pEGFP-C3. pEGFP-C3 encodes a red-shifted variant of 
wild type GFP which has been optimized for brighter fluorescence and higher expression 
in mammalian cells. The multicloning site (MCS) localized between the EGFP coding 
sequences and the SV40 poly A. Gene cloned into the MCS will be expressed as fusion to 
the C terminus of EGFP if they are the same reading frame as EGFP and there are no 
intervening stop codons. The vector backbone contains an SV40 origin for replication in 
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mammalian cells expressing the SV40 T antigen. A neomycin resistance cassette (Neor), 
consisting of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, 
and poly adenylattion signals from the Herpes simplex virus thymidin kinase (HSV TK), 
allows stable transfected eukaryotic cells to be selected using G418.  A bacterial promoter 
upstream of this cassette expresses kanamycin resistance in E.coli. (Clonetech technical 
information).  
 
 
c. pDsRed2-C1 (CLONETECH) 
 
    
 
Figure 9. Schematic drawing of pDsRed2-C1. pDsRed2-C1 encodes DsRed2, a DsRed 
variant that has been engineered for a faster maturation and lower non specific 
aggregation. The MCS is positioned between the DsRed2 coding sequence and the SV40 
poly A. Gene cloned into the MCS will be expressed as fusion to the C terminus of 
DsRed2 if they are the same reading frame as EGFP and there are no intervening stop 
codons. The vector backbone contains an SV40 origin for replication in mammalian cells 
expressing the SV40 T antigen, a pUC origin of replication for propagation in E.coli and an 
f1 origin for single stranded DNA production. A neomycin resistance casette (Neor), 
consisting of the SV40 early promoter, the neomycin/kanamycin resistance gene of Tn5, 
and polyadenylation signals from the Herpes simplex virus thymidin kinase (HSV TK) 
gene, allows stably transfected eukaryotic cells to be selected using G418. A bacterial 
promoter upstream of this cassette expresses kanamycin resistance in E.coli (Clonetech 
technical information). 
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d. pRcCMV-Core  
 
  
 
Figure 10.  Schematic drawing of pRcCMV-Core. pRcCMV-Core expression vector 
derived from expression vector pRcCMV (5.5 kb). The HBV core (557 bp) was subcloned 
into the multicloning site between Hind III and Apa I restriction sites. The vector backbone 
contains an CMV promoter, neomycin and ampicillin resistance gene (Neor and Ampr ). 
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2.2. Methods 
 
2.2.1. Nuclear Localization of Entire HBV Genome in HuH-7 Cell 
To study the nuclear localization of entire HBV genome in hepatoma cell line HuH-7, 
DNA which encodes entire HBV genome from isolate 991 was isolated, purified and 
transfected into HuH-7 cell lines. The nuclear localization of the entire HBV genome was 
determined by immunofluorescent staining under confocal laser microscope and then 
quantified manually (see below).  
 
a. Preparation of Entire HBV Genome 
To prepare the entire HBV genome, plasmid vector pUC-991 which derived from 
pUC-19 and the entire HBV genome from isolate 991, was digested by Eco RI. 1 µl DNA 
pUC-991 (1 µg/µl) was digested with 1 µl Eco RI enzyme (2 U/µl) in total volume 10 µl in 
the buffer recommended by the vendor. After over night incubated at 37°C, the digestion 
products were separated by 1% gel agarose electrophoresis. The gel was stained by 
ethidium bromide (SERVA) and visualized using UV light. The expected bands appear at 
a size of 2686 bp (vector pUC-19) and 3199 bp (entire HBV genome). The 3199 bp band 
was extracted from the agarose gel (SEAKEM) and purified using a gel extraction 
purification kit (QIAGEN) according to the manufacturers recommendations. After that the 
DNA was transfected into HuH-7 cells. 
 
b. Preparation of HuH-7 
HuH-7 cells were seeded on the culture dish (FALCON) and incubated over night in 
the incubator CO2 (HERAEUS) at 37°C. The growing cells were harvested and washed 
with PBS. The PBS was replaced by 1x trypsin in PBS (GIBCO-BRL), which has been 
preincubated at 37°C. While the dish with the cells was incubated at 37°C for 2-5 minutes, 
0.5 ml 10% FCS containing medium (GIBCO-BRL) were added to the each well of 24 well 
dish containing collagen-treated cover slips (NUNC INC). The trypsin in PBS was 
removed and washed the cells with PBS. The PBS was changed with fresh 10% FCS 
containing medium. Each cover slip (MAGV) were filled with 2-5 drops cell suspension. 
Then the cells were allowed to grow over night at 37°C in humidified incubator at 5% CO2. 
 
2.2.2. DNA Plasmid Construction 
a. pEGFP-Core 1C 
Isolation of the HBV core open reading frame (ORF) was performed by digestion of 
1 µl plasmid pRcCMV-Core (1 µg/µl) by the restriction enzyme Apa I (NEB) 5 U/µl  
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overnight at 25°C. The next day, the linear DNA fragment derived from this digest was 
digested with 2 U/µl Hind III (NEB) over night at 37°C. After separation of the DNA 
fragments by 1% agarose gel electrophoresis, the DNA was stained by ethidium bromide. 
Using UV light for visualization, the DNA fragment representing the HBV core ORF (557 
bp) was isolated and purified using a Qiaquick gel extraction kit (QIAGEN). 
To prepare the EGFP expression vector, 1 µl pEGFP-C3 (1 µg/µl) was digested 
with Apa I and Hind III as described above. After gel agarose electrophoresis a 
linear DNA fragment of 4702 bp was isolated and purified using Qiaquick gel 
extraction kit as described above. Enzymatic ligation between vector and insert by 
3 U/µl T4 DNA ligase over night at 20 °C generate pEGFP-Core 1C (5259 bp). 
 
b. pEGFP-Core 2 C 
Five µl DNA of pEGFP-Core 1C (1 µg/µl) were digested by Ava I (NEB) 1 U/µl at 37° 
over night in the recommended buffer. The next day, a further restriction digest by Apa I (5 
U/µl) were performed, and incubated at 25°C over night. The fragments of DNA were run 
on 1% agarose gel electrophoresis, then stained with ethidium bromide. Under UV light  
two linear DNA fragments  are seen in size 25 bp and 5234 bp. The DNA fragment 5234 
bp was purified using standard protocol of Qiaquick gel extraction kit (QIAGEN). The pure 
DNA fragment 5234 kb was used as a vector. 
As insert a synthetic oligonucleotide was used. The DNA insert for pEGFP-Core 2 C 
consist of 78 nucleotides (sense) and 69 nucleotides (antisense). The double stranded 
oligonucleotide contains the restriction sites for Ava I at the 5’ and for Apa I at the 3’ end. 
The hybridization was performed by mixing 10 µl DNA sense and 10 µl DNA antisense 
oligonucleotides that were adjusted to 1 µg/µl. After mixed gently the sample was 
incubated at 95°C for 2 minutes and then cooled down slowly at room temperature and 
was finally placed over night at 4°C. Before ligation, the double stranded oligonucleotide 
was treated with T4 polynucleotide kinase to add a phosphate group to the 5' ends. The 
phosphorylation reaction consists of 10 µl DNA, 3  µl 1 mM ATP (BOEHRINGER), 1 µl (10 
U/µl) T4 polynucleotide kinase (NEB), 5 µl BSA (ROTH) at 50 ng/ml and H20 to a final 
volume of 35.5 µl. The phosphorylation reaction was performed at 37°C for 1 hour.  The 
T4 polynucleotide kinase was inactivated at 65 °C for 20 minutes. Enzymatic ligation 
between this linear vector and synthetic oligonucleotide as described before to generate 
pEGFP-Core 2C (5312 bp). 
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c. pEGFP-Core 3 C 
The experimental procedures to prepare the DNA vector and the insert of the 
synthetic oligonucleotide were performed as described for pEGFP-Core 2C (above). The 
DNA inserts of 3 Core NLS consists of 129 nucleotides (sense) and 123 nucleotides 
(antisense) respectively. Ligation between this linear vector and synthetic oligonucleotide 
generates pEGFP-Core 2C (5363 bp). 
 
d. pEGFP-Core ∆ NLS 
One µl pEGFP-Core 1C (1 µg/µl) was digested by the restriction enzymes Bsp EI 
(NEB) 1 U/µl  and Apa I (NEB) 5 U/µl. The single stranded ends from these digest were 
filled using T4 DNA polymerase (NEB) 40 U/µl in the presence of 1 mM dNTP 
(BOEHRINGER). T4 DNA polymerase can modify  a sticky end strand to the  blunt end 
strand, because of its activities not only as polymerase DNA 5’ to 3’ direction in a present 
of dNTP (BOEHRINGER) but also as exonuclease 3’ to 5’ direction. After enzymatic 
modification, the plasmid DNA was self ligated by T4 DNA ligase 3 U/µl. The self ligation 
product generates pEGFP-Core ∆NLS (5130 bp), which lacks the C-terminus with its NLS. 
 
e. pEGFP-Core 1 SV40 NLS 
One µl pEGFP-Core 1C was cleaved in a double restriction digested using Bsp EI 1 
U/µl and Apa I 5 U/µl enzymes in total volume 10 µl over night at 37°C. 1% agarose gel 
electrophoresis and subsequent stain by ethidium bromide showed two linear DNA 
fragments of 129 bp and 5130 bp. The large fragment was purified as described above 
and used as the vector. The insert of the synthetic oligonucleotide for 1 SV40 NLS 
consists of 47 nucleotides (sense) and 39 nucleotides (antisense), containing the 
restriction sites of Bsp EI at the 5’ and of Apa I at the 3’ end. Preparation of synthetic 
oligonucleotide and phoshorylation was performed as described above. The enzymatic 
ligation between vector and insert generated pEGFP-Core 1 SV40 NLS (5177 bp). 
 
f. pEGFP-Core 2 SV40 NLS 
The experimental procedures for preparation of the vector and the synthetic 
oligonucleotide are described above. The insert of the synthetic oligonucleotide for 2 
SV40 NLS consists of 68 nucleotides (sense) and 60 nucleotides (antisense). The 
enzymatic ligation between vector and insert generated pEGFP-Core 2 SV40 NLS (5198 
bp). 
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g. pEGFP-Core 3 SV40 NLS 
Preparation was performed as for pEGFP-Core 1 SV40 NLS (above). The synthetic 
oligonucleotides for pEGFP core 3 SV40 NLS consists of 92 nucleotides (sense) and 81 
nucleotides (antisense). The enzymatic ligation between vector and insert generated 
pEGFP-Core 3 SV40 NLS (5221 bp). 
 
2.2.3. Ligation 
For ligation 1 µl DNA vector and 5 µl DNA insert were ligated with T4 DNA ligase 
(NEB) 3 U/µl in total volume 10 µl according to manufacture procedures. The enzymatic 
ligation was performed over night at room temperature (20-25°C).  
 
2.2.4. Transformation 
The ligation products were transformed into competent E. coli. 10 µl DNA were 
added into 50 µl competent E. coli XL-1 blue. After gentle mixing, the transformation 
reactions were cooled down on the ice for 10 minutes, then the transformation was 
accomplished by a heat shock at 42°C for 2 minutes. Then 1 ml LB medium was added 
and mixed gently. The E. coli were incubated at 37°C for 1 hour and platted onto an agar 
dish containing LB medium with 30 µg/ml Kanamycin. The dish was incubated at 37°C 
until the liquid has been absorbed. Then the dish was inverted and incubated over night at 
37°C.  
 
2.2.5. Minipreparation DNA Plasmid Isolation 
After 16 hours, the bacterial colonies appeared. Using sterile yellow tips, the 
bacterial colonies were picked and grown in 2 ml Kanamycin (30 µg/ml) containing LB 
medium. The colonies were incubated in shaking incubator at 37°C overnight. The next 
day, 1.5 ml bacteria in LB medium was harvested and centrifuged at 6500 rpm for 5 
minutes at room temperature. Supernatant was removed and the bacterial pellet was 
resuspended in 300 µl resuspension buffer (P1 buffer). Afterwards 300 µl lysis buffer (P2 
buffer) was added before 300 µl neutralization buffer (P3 buffer) were added. The mix was 
centrifuged at 12.000 rpm for 10 minutes at room temperature. The clear supernatant was 
collected and the plasmid DNA was precipitated by adding 0.7 volumes of isopropanol. 
The solution was mixed gently and centrifuged immediately at 14000 rpm for 15 minutes 
at 4°C. The supernatant was decanted carefully and the DNA pellet were washed with 500 
µl 70% ethanol and dried on air for 5-10 minutes. The DNA was dissolved in 20 µl H20. An 
aliquot (0.5 ml) the bacteria was stored at 4°C.   
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2.2.6. Restriction Analysis  
To restriction analyse of pEGFP-Core 1C  was used Bgl II. 1 µl DNA plasmid from 
each minipreparation sample was digested with 1 µl Bgl II (10 U/µl) in the 10 µl total 
volume. After over night incubation at 37°C, DNA fragments were run in 1% agarose gel, 
then stained by ethidium bromide. The same restriction analysis was performed using Apa 
I (50 U/µl) and Hind III (20 U/µl) enzymes. To restriction analysis of  pEGFP-Core 2C and 
3C were used also Apa I  (50 U/µl) and Hind III (20 U/µl) enzymes. In contrast, Bsp MI (2 
U/ µl) was used to restriction analyse of pEGFP-Core ∆ NLS, pEGFP-Core 1 SV40 NLS, 
pEGFP-Core 2 SV40 NLS and pEGFP-Core 3 SV40 NLS. Digestion procedures were 
performed as described by Bgl II (above).  
 
2.2.7. Maxipreparation  DNA Plasmid Isolation. 
After restriction analysis, the 0.5 ml of the positive clones were used to inoculate 250 
ml LB kanamycin selective medium. The bacteria were grown at 37°C for 12-16 hours with 
shaking (300 rpm). The next day, 5 ml bacteria in LB medium were removed and 5 ml 
glycerine (MERCK) was added. This mixture was stored at -20°C. The remaining bacteria 
were sedimented and the plasmid DNA was isolated using a maxipreparation kit 
(QIAGEN). This preparation was performed according to the manufacture 
recommendations. 
 
2.2.8. Preparation of Cell Culture 
The cell cultures (HuH-7 and HepG2) were seeded on the culture dish and 
incubated in the incubator CO2 at 37°C. After over night incubation, the growing cells were 
harvested and washed with PBS. The PBS was replaced by 1x trypsin in PBS, which has 
been preincubated in waterbath at 37°C for 10 minutes. While the dish with the cells was 
incubated at 37°C for 2-5 minutes, 0.5 ml 10% FCS containing medium were added to the 
each well of 24 well dish containing collagen-treated cover slips. The trypsin in PBS was 
removed and washed again the cells with PBS. The PBS was changed with fresh 10% 
FCS containing medium. Each cover slip were filled with 2-5 drops cell suspension. Then 
the cells were grown over night at 37°C in humidified incubator at 5% CO2. 
 
2.2.9. Transfection  
Tfx-20 (PROMEGA) was used as transfection agent. For each well, 1 µl DNA (1 
µg/µl) was mixed gently with 3 µl Tfx-20, which was than mixed with 300 µl FCS-free 
medium (GIBCO-BRL). The mixture was incubated at room temperature for 5-10 minutes. 
During the incubation, the medium in the 24 well dish were removed and replaced with 
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FCS free medium. The DNA/Tfx-20 reagent/FCS-free medium mixture were vortexed 
briefly, then added the mixture to the cells (300 µl per well) and incubated in the incubator 
at 5% CO2 and 37 °C for 1 hour. During the incubation 10% FCS containing  medium was 
warmed at 37°C in the waterbath. After 1 hour the FCS free medium was replaced with 
the 10% FCS containing medium and the dish was returned into the incubator for 24-48 
hours.  
 
2.2.10.  Inhibitor Treatment  
a. Staurosporine  
Different concentrations of Staurosporine (10 nM, 40 nM and 100 nM) were added to 
cultured HuH-7 and HepG2 cells for different times (30 minutes, 1 hour, 2 hours, 4 hours 
and overnight) to determine the toxicity. After the incubation the cells were stained with 
Trypan blue. Dead cells  appeared blue, whereas living cells remained transparent. Based 
on the result, HuH-7 cells tolerated Staurosporine (SIGMA) at 40 nM overnight, whereas 
HepG2 cell tolerated 100 nM overnight. For analyzing the effect of Staurosporine on the 
localization of the fusion proteins the plasmids were transfected and the inhibitor was 
added 1 hour post transfection before the transfected cell lines were incubated over night 
at 37°C.   
 
b. Bayer 41-4109 
One hour post transfection, the medium was changed and FCS free medium 
containing Bayer 41-4109 in final concentration 10 nM was added before further 
incubation at 37°C over night. 
 
2.2.11. Indirect Immune Fluorescence 
Cells were fixed on the cover slips with 3% paraformaldehyd (PFA) (SIGMA) in 
PBS at room temperature for 30 minutes. After fixation the cells were washed with 1x PBS 
three times before each well was filled with 500 µl 0.1% Triton X-100 (SERVA). The dish 
was incubated at room temperature for 10 minutes in order to permeabilize the cell 
membranes. After that, the wells were washed three times with 1x PBS three times. In the 
primary antibody mixture, mAb 414 was diluted in 1: 300 in antibody solution (1x PBS / 
5% BSA/ 5% goat serum), whereas the anti capsid antibody was diluted 1: 200. For each 
cover slip 40 µl antibody mixture spotted on parafilm in a humidified box. The cover slips 
were placed with their cell side on the drop of antibody mixture. The humidified box was 
incubated at 37°C in the incubator. After 1 hour, the up side of cover slips were rinsed with 
100 µl 1x PBS before replaced in the 24-well dish. The 24 well dish was washed three 
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times with 1x PBS. For secondary antibody reaction a goat Texas Red-labelled anti 
mouse antibody and an Alexa488 goat anti rabbit antibody were diluted 1: 100 in antibody 
solution. Forty of this antibody mixture was spotted on parafilm in the humidified box 
followed by transfer of the cover slips as described before. The box was incubated at 
37°C for 45 minutes, the cover slips were rinsed, replaced and washed as described. 
Drops of Dabco-Moviol (SIGMA-HOECHST) were spotted on microscopical glass slides 
and the cover slips were placed on them. The glass slides were kept over night in the 
darkness at room temperature. 
 
2.2.12. Immune Fluorescence Confocal Laser Microscopy 
A drop of immersion oil was dripped on each of cover slips in the slide. The slide 
was put on the microscope. The cells were analyzed using a 63x apochromat objective by 
a LEICA DM IRBE. For the confocal analysis the cells were scanned by a laser power of 
30%, a signal amplification of 85% and a pinhole size of 0.9 with a two-fold magnification. 
Eight pictures were merged. For the representation of Alexa 488, the FITC filter  settings 
were used, for depicting Texas Red, the TRITC filter setting were used. The z position in 
all picture was adjusted to the equatorial level of the nuclei. The pictures were arranged 
using the ADOBE-PHOTOSHOP software program.     
 
2.2.13. Quantification of the Intracellular Localization 
The HBV capsid protein which found localized in the compartment of HuH-7 cells, 
was quantified manually using confocal laser microscope. The Amount of HBV capsid that 
found localized in the cytoplasm, nucleus or both of transfected were quantified in the 
absolute and relative values. 
 
2.2.14. Quantification of the Cell Division  
Two different cell lines (HuH-7 and HepG2) were seeded on a culture dish in the 
different concentration of FCS (2.5% and 10%). Then the cells were incubated over night 
in the incubator CO2 at 37°C. After 24 hours, the growing cells were harvested and 
collected into 15 ml conical tube. The conical tube was centrifuged at 4500 rpm for 15 
minutes, the supernatant was removed and pellet was resuspended by 1 ml medium. The 
cell suspension was mixed by vortexing. To calculate the start number of cell, 10 µl of cell 
suspension was pipetted into a haemocytometer counting chamber (NEUBAUER). The 
same number of cells were seeded and incubated at different serum concentration for 48 
hours before the cell number was determined again. 
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2.2.15. Dimerisation Analysis of EGFP-Core 1C Fusion Protein. 
Dimerization was analysed by immune precipitation using an anti-EGFP antibody. 
Therefore, pEGFP-core 1C vector was transfected into HepG2.2.15 cells that stably 
express the HBV genome. 
 
a. Preparation of Cell Line and Transfection pEGFP-Core 1C into HepG2.2.15 
HepG2.2.15 cells were grown on the collagenized culture dish. In the DMEM 10% 
FCS, the cells were incubated over night at 37°C. 30 µl DNA of pEGFP-Core 1C in 
concentration 1 µg/µl were transfected into HepG2.2.15 cells on a 6 cm culture dish. The 
cells were expended until 20 dishes (15 cm) could be harvested. 
 
b. Isolation of Lysate from  the Transfected Cells 
Lysate was made from 20 dishes of growing cells. Cells were harvested using a 
rubber policeman in 1 ml PBS per dish. The cells were collected in a 50 ml conical tube 
and the cells were sedimented at 4500 rpm for 30  minutes at 4°C. The pellet was 
resuspended in 5 ml PBS and subjected to 3 freeze and thawing cycles in liquid nitrogen 
and at 37°C in a water bath. Then Triton X-100 was added to a final concentration of 0.1% 
and the solution was incubated at  37°C for 10 minutes followed by sonification using an 
ultrasonic sonicator (in 70% maximal capacity) for 60 seconds for three times. Insoluble 
components were removed by centrifugation at 15000 rpm for 20 minutes at 4°C. The 
lysate was treated with 20 ng/ml RNaseA, 20 U/ml S7 nuclease in 15 mM MgCl2 for 1 hour 
at 37°C. The lysate was concentrated using a Nanosept 3K centrifugal concentrator at 
4°C. 
 
c. Concentration of EGFP-Core Fusion Protein 
Nanosep 3K (PALL FILTRON) centrifugal concentrators were used to concentrate  
the lysate.  In 2.5 ml of lysate 50 µl 1 mM DTT were added. 500 µl lysate was pipetted into 
sample reservoir of Nanosep 3K. Then the Nanosep 3K was centrifuged at 10000 rpm at 
4°C until it was concentrated to 100 µl.  
 
d. Phosphorylation using 32γATP 
Before used, lysate of HepG2.2.15 (20 µg/µl) was phosphorylated using 10 µci 32γ 
ATP (AMERSHAM PHARMACIA). By adding protease inhibitor, the phosphorylated 
lysates were incubated at 37°C for 3 hours. 
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e. Co-immune Precipitation 
Thirty µCi [γ32P]ATP and a protease inhibitor mixture (complete, EDTA-free tablet; Roche) 
was added to the lysate, which was adjusted to pH 7.0, 10 mM MgCl2, 0.2 mM CaCl2.and 
than incubated for 3 hours at 37°C. For immune precipitation 10 µL anti rabbit-coated 
biomagnetic beads (DYNAL) were incubated over night with 10 µl of anti capsid antibody 
(DAKO) in 100 µl PBS/0.1% BSA at 4°C. Unbound antibodies were removed using 
magnetic absorption to the wall of the tube. The pellet was dissolved in 150 µl PBS/0.1 % 
BSA and absorbed again. The washing was done 3 times. When precipitation was 
performed with the anti EGFP antibody, anti mouse coated biomagnetic beads and a 
monoclonal anti EGFP antibody were used instead. The beads were subjected to 300 µl 
of lysate over night at 4°C on a rotating wheel. The beads were washed 2 times with 1 ml 
PBS/0.1 % BSA and 1 x with PBS/0.1 % NP-40. The cups were changed for every 
washing step. Finally, the pellet was resuspended in 20 µl 1 x loading buffer, 5 min 
denaturated at 95°C and loaded onto a 4 - 12 % SDS PAGE (INVITROGENE). The gel 
was dried under vacuum at 80°C followed by exposure of a phosphoimager screen. After 
3 days the screen was developed on a phosphoimager. 
 
 
f. SDS PAGE  
Each sample consists of 15 µl sample, 3.5 µl Nupage loading buffer 
(INVITROGENE) and 1.5 µl (1 mM) DTT (SIGMA). All samples were heated at 95°C for 
10 minutes before loading. 20 µl were loaded. The electrophoresis apparatus 
(INVITROGENE) was attached to an electric power supply, a voltage was applied of 
8V/cm to the gel. Then the voltage was increased to 15 V/cm and the Tris-Base 4-12% gel 
(INVITROGENE) was run until the bromophenol blue reaches the bottom of the resolving 
gel. The gel was dried under vacuum at 80°C followed by the exposure to a 
phosphoimager screen.  
 
 
g. Phosphoimager Screening  
A phosphoimager plat is a re-useable plat. Before used, the plat has to be cleaned 
from useless image by laser light for 20 minutes. The dried SDS gel was laminated and 
laid on the phosphoimager. To develop the  image, the plat was exposed and stored in the 
casette (AMERSHAM PHARMACIA) and then incubated at room temperature in the dark 
room.  After 3 days exposition, the phosphoimager plat was scanned by Typhoon 9200 
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(AMERSHAM PHARMACIA). Pictures were saved in IMAGE SQUAN program and 
worked in ADOBE PHOTOSHOP software program.  
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3. Results 
3.1. Nuclear Localization of HBV Capsids After Transfection of the Entire HBV  
       Genome into HuH-7 Cells 
 
Immunohistochemical detection of the HBV core protein in human livers from HBV 
infected individuals shows that the HBV capsid stain occurs predominantly within the 
nucleus (Akiba et al., 1987; Serinoz et al., 2003). Nuclear localization was also observed 
in mice transgenic for HBV (Guidotti et al., 2002). Using this system it was shown that the 
nuclear membrane is impermeable for the entire capsid. Since liver cells divide only 
rarely, the nuclear capsids must be thus derived from capsid protein that either diffuses 
through the nuclear pore or from capsid protein that is actively transported through the 
pores. In both scenarios capsid formation occurs within the nucleus when the capsid 
protein concentration exceeds the minimal assembly concentration, as it was determined 
by others (Seifer and Standring, 1995). 
To study the nuclear localization in more detail, I analysed the localization of the 
capsid and different core fusion proteins in human liver cell lines by transfection. First, the 
capsid was transiently expressed in the hepatoma cell line HuH-7 to validate whether 
transfection results in the same capsid localization than in human livers. 
 
Eco RI
linear HBV Genome (3.221 bp)
Eco RI Eco RI
Transfection
Eco RI
pUC-991
(5.907 bp)
1
396
Ampicilin vector pUC-19 (2.686 bp)
amp
linear HBV Genome (3.221 bp) 
linear HBV Genome (3.221 bp) 
Eco RI
Purification 
 
Figure 11. Preparation and transfection of the 
linear HBV genome into HuH-7 cells. Plasmid 
pUC-991 was digested with Eco RI. The digestion 
products were separated by 1% gel agarose 
electrophoresis. The 3221 bp band of the 
linearized HBV genome was purified and 
transfected into HuH-7 cells 
In vivo the HBV transcripts are 
synthesized from a circular HBV 
DNA genome with overlapping 
promoters and open reading frames 
(ORF). Consequently, it cannot be 
excluded that a promoter is down-
regulated by transcription of an 
overlapping ORF. In order to 
prevent artefacts by overexpression 
the capsid was thus expressed in 
the context of the HBV genome 
(experimental scheme in Fig. 11). 
Although the HBV genome has to 
be circular to express all viral gene 
products, a linear genome was used 
since circularization occurs after 
transfection, as it was determined 
by others (Sterneck et al., 1998). 
Plasmid pUC-991 that contains 
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a full-length   linear  HBV   genome  
of genotype D (EMBL accession no. 
 
Figure 12. Cleavage products of plasmid pUC-991 
by Eco RI. Ethidium bromide stain after agarose gel 
electrophoresis. Plasmid pUC-991 contains a monomer 
of the HBV genome (isolate 991) cloned via the single 
Eco RI restriction site within the vector pUC-19. S 
shows the reaction products of an EcoRI digest. The 
vector backbone migrates as a linear DNA fragment of 
2686 bp, the HBV genome migrated slower 
representing 3221 bp. M: DNA molecular weight 
marker (1 kb plus DNA ladder).  Electrophoresis was 
done on a 1% agarose gel in TAE.  
 
 
 
 
Figure 13. Electrophoresis of the linear purified 
HBV-991 genome. S shows the HBV-991 genome 
after purification. No contamination to the vector could 
be observed. M indicates the molecular weight marker. 
Electrophoresis and staining were done as in Figure 
12. 
 
X51970) was digested by Eco RI 
allowing the separation of the HBV 
genome from the vector backbone. 
In this linearized HBV genome the 
ORFs of polymerase and surface 
protein are discontinuous but the 
overlapping X-transcription and 
core-transcription units are 
unaffected. After separation of the 
cleavage products on an agarose 
gel and subsequent ethidium 
bromide stain two cleavage 
products of 3221 bp (Fig. 12) 
representing the HBV genome and 
2686 bp representing the pUC 
vector were detectable. The 3221 
bp band was isolated, purified (Fig. 
13) and transfected into HuH-7 
cells. Twenty four hours after  
transfection, the transfected cells 
were fixed and an indirect immune 
stain against the capsid was 
performed (Fig. 14). To verify the 
location within the cell, an additional 
co-stain against the nuclear pore 
complexes (NPC) was done. The 
distribution of the capsid (depicted 
in green) and NPC (in red) was 
analysed by confocal laser scan 
microscopy. The observed 
localizations were classified in a 
number of cells as to be 
predominantly intranuclear, 
cytoplasmic or equally distributed 
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within these compartments. 
Representative fluorescence results 
are depicted in Fig. 14, the 
frequency of the distribution is 
shown in Tab. 1. 
 
 
  
Cytoplasm Nucleus Both Total 
26 71 3 100 
26% 71% 3% 100% 
 
 
Figure 14. Indirect immune 
fluorescence of the HBV capsid in 
HuH-7 cells. Capsids were stained 
using an anti-capsid primary antibody 
and a FITC-labeled secondary antibody. 
The staining patterns are depicted in 
green (left column). The control stain of 
the NPCs was performed using a 
monoclonal antibody (mab) 414 as 
primary antibody and a Texas Red-
labeled secondary antibody, which is 
shown in red (middle column). The 
overlay of both staining is shown in the 
right column. The panels show examples 
of cytoplasmic (upper row), nuclear 
(middle row) and an equal distribution 
(lower row). 
 
 
 
 
Table 2. Distribution of HBV capsids 
after transient transfection of the HBV 
genome into HuH-7 cells. Absolute and 
relative numbers of cells showing an 
equal distribution or a predominantly 
nuclear or cytoplasmic localization of 
HBV capsids. 
 
   
 As in human HBV-infected livers, the HBV capsid staining was predominantly 
found within the nucleus (71%). Less frequently, the capsid localized within the cytoplasm 
(26%). Since the used anti capsid antibody recognizes capsid protein monomers and 
dimers at least 240 fold less than assembled capsids (Kann et at., 1999), it must be  
concluded that the stain reflects assembled capsids instead of unassembled capsid 
protein. 
Only in a minority of cases, the capsids were found to show a more or less equal 
distribution between cytoplasm and nucleus (3%). This low frequency indicates that the 
capsids are not diffusing within the cells being in accordance to the in vivo situation in 
which the nuclear membrane is impermeable for the capsid. However the significant 
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number of cells that show different localizations indicates that the cells differ either in their 
nuclear transport capacity or in that they modify the core protein in a way that affects its 
nuclear import.  
It was previously reported that the HBV capsid protein contains a nuclear localization 
signal (NLS) within amino acid 157-168 (PRRRTPSPRRR) (Kann et al., 1999) that 
interacts with the nuclear transport receptor importin α. This complex binds to importin ß 
that facilitates the nuclear transport of the capsid (Kann et al., 1999, Rabe et al., 2003). 
The consensus motif for monopartite NLS is K-(K/R)-x-(K/R). Based on co-
crystallisation of importin α with SV40 Tag and Lamin B2-NLS, it was proposed that NLS 
must contain a Lysine residue within the NLS that interacts with the binding pocket P2 of 
the importin α molecule (Fontes et al., 2000). The larger side chain of arginine should, 
according to this study, prevent efficient interaction between NLS and importin α. 
The HBV capsid NLS should thus show only a weak interaction importin α but a 
similar NLS has been described for the HIV Vpr protein (Sherman et al., 2001). However, 
Vpr is part of the HIV preintegration complex that contains multiple NLS on different 
proteins (Vpr, MA, integrase) while nuclear transport of the HBV capsid protein is not 
supported by other karyophilic proteins. On the other hand, on capsids or assembly 
intermediates the HBV NLS is exposed in redundancy. Such a multiple exposure of an 
NLS increases the probability of interactions with importin α, assumed to enhance 
transport competence. Alternatively, additional interactions between the capsid protein 
and importin α outside the NLS-binding pocket may stabilize the importin α-NLS 
interaction, as it was shown previously for the BDV protein p10 (Wolff et al. 2000). 
To analyze whether the redundancy of the HBV capsid NLS is a prerequisite for 
nuclear import, fusion proteins of the capsid protein and fluorescent marker proteins were 
expressed. It has been shown recently that N-terminal fusions of larger polypeptides to 
the amino-terminus of the core protein prevent capsid assembly (Koletzki et al., 1999). 
 
3.2. Analysis of different Fluorescent  Marker Proteins 
 
First, I investigated the intrinsic localization of two commonly used marker proteins, 
DsRed (red fluorescencent) and EGFP (green fluorescent) by transient expression of the 
corresponding expression vectors pDsRed2-C1 and pEGFP-C3 in HuH-7 cells (Fig. 15a 
and b). Both proteins were expressed under the control of the PCMV promoter. The 
transfection and cell culture conditions were identical to those used for the expression of 
the HBV capsid in the experiment before. As in this experiment, the staining of the NPCs 
was done  using  the same  primary  antibody.  In pDsRed2  transfection  an FITC-labelled 
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        NPC        DsRed       merge 
 
Figure 15a. Localization of DsRed in HuH-7 cells. 
DsRed (middle column) was found to be localized inside 
the cytoplasm (upper row) and within the nucleus (lower 
row) in a similar amount of cells. The nuclear pore 
complexes are shown in green; the overlays (merge) in 
the right column. 
 
 
      EGFP        NPC        merge 
 
Figure 15b. Localization of EGFP in HuH-7 cells. In 
the majority of cells EGFP (green) localized 
predominantly in the cytoplasm (upper row). In a 
minority of cells EGFP was localized nucleus (midlle 
row) or throughout cytoplasm and nucleus (lower row, 
right cell). The nuclear pore complexes are shown in 
red; the overlays (merge) in the right column. 
 
 
 
secondary antibody was used. For 
localisation of EGFP the secondary 
antibody was Texas Red labelled. 
Both transfections were done in 
parallel to exclude differences 
caused by the pre-cultivation of the 
cells prior to transfection. The 
number of cells showing a 
predominantly nuclear or 
cytoplasmic distribution was 
quantified (Tab. 2). 
A proportion of both proteins 
localized inside the nucleus. In 
both cellular compartments both 
fusion proteins were distributed 
disperse, showing no association 
to cellular structures. They were 
only rarely found in both, 
cytoplasm and nucleus indicating 
that they are not freely diffusing. 
The significant number of cells 
showing a nuclear fluorescence 
however indicates that either both 
proteins are weakly karyophilic or 
that they are passively trapped 
upon reconstitution of the nuclear 
membrane following cell division. 
Since DsRed form tetramers with a 
resulting molecular weight of 89 
kDa, a passive trapping upon cell 
division appears more likely 
assuming a diffusion limit of 
approximately 40-45 kDa through 
the nuclear pores (Dingwall and 
Laskey, 1992).  
37
 
Results 
_________________________________________________________________________ 
 
marker cytoplasm nucleus  both total 
DsRed2  7 10 0 17 
  41% 59% 0 100% 
EGFP 100 39 1 140 
  71% 28% 1% 100% 
Table 3. Distribution of DsRed and EGFP in HuH-7 
cells after transient expression. Absolute and relative 
numbers of cells showing an equal distribution or a 
predominantly cytoplasmic or nuclear localization of the 
fusion proteins. Both transfections were done in parallel. 
EGFP shows a much higher 
proportion of cytoplasmic 
localization, thus being more 
suitable for analysis of the HBV 
capsid NLS than DsRed. However, 
the significant proportion of nuclear 
EGFP showed that determination 
of the ratio of cells showing nuclear 
and/or cytoplasmic fusion protein is 
required. 
 
 
 
3.3. Transport Competence of EGFP-Core Fusion Proteins 
 
3.3.1. Cloning of pEGFP-Core Fusion Protein  
 
To analyse the nuclear transport capacity of the capsid NLS a vector encoding 
EGFP that was fused in frame to the N-terminus of the capsid protein. For construction of 
this expression vector, plasmid pEGFP-C3 was cleaved by the restriction enzymes Apa I 
and Hind III that digest the vector within the multiple cloning site (MCS) downstream of the 
EGFP ORF. To obtain the capsid ORF, plasmid pRcCMV-Core was cleaved by the same 
restriction enzymes generating a 557 bp fragment that comprises the entire HBV core 
ORF (cloning strategy depicted in Fig. 16). The ethidium bromide staining of the purified 
DNA vector and insert after agarose gel electrophoresis is depicted in Fig. 17.  
After ligation, the DNA was analyzed by analytical agarose gel electrophoresis 
showing different ligation products around 5-6000 bp (Fig. 18) that may reflect linear and 
circularized vector-insert ligation products. After transformation of E. coli XL-1 Blue, the 
plasmids in the obtained clones were subjected to two restriction analyses using Bgl II and  
Apa I/Hind III. An example is given in Fig. 19. Bgl II digests within the core ORF, 
generating fragments of 24 bp, 421 bp and 4814 bp, whereas a digest by Apa I and Hind 
III removes the entire insert thus generating a 557 bp and a 4702 bp fragment (see 
restriction map in Fig. 20). 
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Hind III
Apa I
Ligation
Hind III
   Apa I
pEGFP-C3
(4.737 bp)
EG
FP
CMV
pEGFP-C3
(Linear)
4.702 bp
EGFP
CMV
pRcCMV-Core
(5,5 kb - 557 bp)
am
p
Core
MCS
vector insert
CMV
V
V
Hind III                                           Apa I
pEGFP-Core 1C
      (5.259 bp)
NLS
HBV core 
589 bp 736 bp
 ATG
   Start codon
 TCC CTT  AGA AGA AGA ACT CCC TCG CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC AGA AGA TCT CAA TCT CGG GAA TCT CAA TGT AGG GCC CTATAG 
157-S  R  S  Q   S  P   R  R   R  R   S  Q   S  R   E  S  Q  C -185 AAP    R  R  R   T   P   S  P   R  R   R   stop
Apa I
CMV
         557 bp
kan
kan
EGFP
kan
 
 
Figure 16. Cloning strategy of pEGFP-Core C1. Plasmids pEGFP-C3 and pRcCMV-Core were 
digested with Apa I and Hind III. After separation by agarose gel electrophoresis, the DNA 
fragments of 4702 bp (pEGFP-C3) and 557 bp (pRcCMV-Core) were purified and ligated with T4 
DNA ligase.  
 
 
 
 
 
Figure 17. Purified vector and insert for 
cloning pEGFP-Core 1C. 1: 4702 bp vector-
fragment derived from the Hind III and Apa I 
digest of plasmid pEGFP-C3. 2: 557 bp insert 
obtained from pRcCMV-Core, digested with 
Hind III and Apa I. M: DNA molecular weight 
marker 1 kb plus DNA ladder. The fragments 
were separated on a 1% agarose gel and 
stained with ethidium bromide. 
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Figure 18. Analysis of the pEGFP-Core C1 
ligation products. L: Ligation products for the 
generation of pEGFP-Core 1C. M: DNA 
molecular weight marker 1 kb plus DNA ladder. 
The ligation products were separated on a 1% 
agarose gel and stained with ethidium bromide. 
 
 
Figure 19. Restriction analysis of a positive 
pEGFP-Core C1 clone. Lane 1:  pEGFP-Core 
1C was digested with Bgl II enzyme showing 
bands of 421 bp and 4814 bp. The estimated 
position of the 24 bp fragment is indicated. 
Lane 2: pEGFP-Core 1C was digested with 
Hind III and Apa I showing a 4702 and a 557 bp 
band. M: DNA molecular weight marker 1 kb 
plus DNA ladder. The fragments were 
separated on a 1% agarose gel and stained 
with ethidium bromide. 
 
  
 
 
 
    
  
CMV
Bgl II
Bgl II
Bgl II
C
or
ekan ) 421 bp
) 24 bp ) 
pEGFP-Core 1C
    (5.259 bp)
 
 
 
Figure 20. Restriction map of pEGFP-Core C1 for Bgl II, Hind III and Apa I. 
.  
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3.3.2. Localization of EGFP-Core 1C 
 
Having obtained the expression plasmid termed EGFP-core 1C (1C = one capsid 
NLS) it was transiently expresseded into HuH-7 cells. This transfection and staining was 
done in parallel to the transfection of pEGFP-C3 described above and is depicted in Fig. 
21. The number of cells showing a predominantly nuclear or cytoplasmic localization of 
the fusion protein was quantified (Tab. 3). 
  
 
 
Figure 21. Localization of EGFP-Core 1C in HuH-
7 cells. The fusion protein is shown in green (left 
column), the NPCs are stained by indirect immune 
fluorescence and are depicted in red (middle 
column). The overlay (merge) is shown in the right 
column. The shown cells are representative for 1 to 
51 cells showing this EGFP-Core 1C protein 
distribution. Examples for the localization of EGFP 
without the capsid protein domain are given in Fig. 
15b. 
 
Figure 21 shows examples of the 
distribution of EGFP-Core 1C protein. 
Within both compartments the fusion 
protein enriches in distinct foci (middle 
row). The pattern differed from that of 
EGFP that shows a homogeneous 
distribution, from that of the capsid as 
shown after transfection of the entire 
HBV genome and from the nuclear 
capsid staining after subjection of virus-
derived capsids to Digitonin-
permeabilized cells (Rabe et al., 2003). 
The speckled nuclear staining is 
however in accordance with the 
previous observation of Vlachou who 
subjected a conjugate of FITC-BSA 
with the HBV capsid NLS to Digitonin-
permeabilized cells (Vlachou, PhD 
thesis, 1999). It may be thus 
speculated that the exposed NLS leads 
to another intranuclear distribution than it is found for the assembled capsids that do not 
expose the C-terminus on their surface. Most likely an interaction of this RNA-binding 
region causes an interaction with single stranded nucleic acids as it was described by 
others (Melegari et al., 1991). 
   
Quantifying the ratio of cells with a predominantly cytoplasmic and nuclear 
distribution (Tab. 3) shows a difference to the EGFP protein in that the number of cells 
with a nuclear staining was nearly doubled from 28% (EGFP) to 54% (EGFP-Core 1C). As 
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in all experiments before only a minority showed localization in both cytoplasm and 
nucleus arguing against passive diffusion. 
 
expressed protein cytoplasm nucleus  both total 
EGFP-Core 1C 43 51 1 95 
  45% 54% 1% 100% 
EGFP 100 39 1 140 
  71% 28% 1% 100% 
 
Table 4. Distribution of EGFP and EGFP-Core 1C in HuH-7 cells after transient expression. 
The distribution of EGFP-Core 1C protein was analysed in 95 cells. The fusion protein 
predominantly localized within the nucleus while EGFP localizes mainly in the cytoplasm. Both 
transfections were done in parallel. 
 
It must be thus concluded that the capsid protein has some transport capacity 
although being unable to translocate all fusion proteins through the nuclear pore into the 
karyoplasm. However, since the difference was not striking, transient expression of the 
EGFP-core 1C protein was repeated three times in order to analyse the reproducibility of 
the assay and to validate the results (Tab. 4). 
 
 
no. expressed protein cytoplasm nucleus both total 
1. EGFP-Core 1C 43 51 1 95 
    45% 54% 1% 100% 
2. EGFP-Core 1C 14 25 1 40 
    35% 64% 1% 100% 
3. EGFP-Core 1C 40 64 1 105 
    38% 61% 1% 100% 
4. EGFP-Core 1C 33 36 0 69 
    48% 52% 0% 100% 
 
Table 5. Localization of EGFP-Core 1C fusion protein in HuH-7 in different transfections 
done at different time points. The transfections were done at different times using the same 
plasmid stock for transfection. The nuclear localization was found in 52% - 64% of the cells. 
Corresponding, cytoplasmic localization ranged between 35% - 48%.  
 
 
Although differences up to 13 % were observed between the different experiments, 
the fraction of cells showing nuclear fusion protein localization was always higher than the 
cells expressing EGFP without the capsid domain. Overall however the nuclear import 
capacity of the capsid protein appears to be not strong. 
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3.4. Localization of EGFP-Core Fusion Proteins with Redundant NLS in HuH-7 Cells.      
3.4.1. Cloning of EGFP-Core 2C, 3C and ∆C Fusion Protein   
3.4.1.1. EGFP-Core 2C 
 
To analyse the strength of the core NLS, EGFP-Core 1 C was compared with other 
EGFP-Core fusion proteins, which comprised the capsid NLS either in a duplet or a triplet. 
The generation of the respective pEGFP-Core vectors was done by digesting pEGFP-
Core 1C by Ava I and Apa I, followed by ligation with a double stranded synthetic 
oligonucleotide that encodes the amino acid sequence SPRRRTPSPRRRRSQSPRRRR 
in frame with the core ORF. The oligonucleotide harboured the restriction ends of Ava I 
and Apa I and was phosphorylated at their 5' ends. The cloning strategy is depicted in   
Fig 22. 
 
pEGFP-Core 
    (5.259 bp)
1C
NLS
pEGFP-Core 
        (linear)
      (5.234 bp)
1C
Apa I   Ava I
CMV
CMV
Apa I & Ava I
 GAA TCT CAA TGT CCT AGA AGA AGA ACT CCC TCG  CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC TAG GGC C
synthetic oligonucleotides (78 bp)
Ava I                                                          Apa I
589 bp 736 bp
 ATG
   Start codon
 CT CGG GAA TCT CAA TGT  CCT AGA AGA AGA ACT CCC TCG CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC  AGG GCC CTA TAG 
  R  E  S  Q   S   P   R  R  R   T  P    S  P   R  R   R  R   S  Q   S  P   R   R stop
Apa IAva I
CMV
pEGFP-Core 
    (5.312 bp)
2C
NLS
NLS
kan co
re
kan
EGFP
kan
co
re
co
re
EGFP
EGFP
   
Figure 22. Cloning strategy of pEGFP-Core 2C. Plasmid pEGFP-Core 1C was digested with Ava 
I and ApaI. The large linear DNA fragment was ligated with a double stranded oligonucleotide 
encoding the capsid NLS.  
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After transformation of E. coli  XL-1 blue, the plasmids in the obtained clones were 
purified and analyzed by restriction digests using Hind III and Apa I. Positive clones (lanes 
1 and 6) showed two bands DNA of 610 bp and 4702 bp (Fig. 23). 
 
   
 
Figure 23. Restriction analysis of EGFP-Core 2C clones. Plasmid preparations of DNA from 10 
clones were digested with Hind III and Apa I. The fragments were separated by 1% agarose gel 
electrophoresis followed by ethidium bromide staining. Lanes 1 and 6 show correct digestion 
products in which 2 bands of 610 bp and 4702 bp appear. M: DNA molecular weight marker 1 kb 
plus DNA ladder.  
 
 
 
3.4.1.2. EGFP-Core 3C 
 
To express an EGFP-Core fusion protein with a triple HBV core NLS the same 
cloning strategy as for generation of the pEGFP-Core 2C vector was used. The large 
pEGFP-Core Ava I and Apa I cleavage fragment was used as the backbone but a 
synthetic oligonucleotide encoding the amino acid sequence  SPRRRTPSPRRRRSQSPR 
RRRSPRRR TPSPRRRRSQSPRRRR was inserted (see Fig. 24). 
After transformation of E. coli XL-1 Blue, the plasmids in the obtained 10 clones 
were purified and analyzed by restriction digests using Hind III and Apa I. Positive clones 
(lane 1, 8 and 10) showed the expected two bands DNA of 661 bp and 4702 (Fig. 25).  
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pEGFP-Core 1C
  (5.259 bp)kan
NLS
pEGFP-Core 
      (linear)
   (5.234 bp)
1C
Apa I   Ava I
CMV
CMV
Apa I & Ava I
GAA TCT CAA TGT CCT AGA AGA AGA ACT CCC TCG  CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC
S Q S P R R R T  P S  P R R R R  S Q S P R R
synthetic oligonucleotides (129 bp)
Ava I  
EGFP
589 bp 736 bp
CCT AGA AGA AGA ACT CCC TCG  CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC TAG GGC C
P R R R T  P S  P R R R R  S Q S P R R stop
CMV
pEGFP-Core 3C
    (5.363 bp)
NLS
co
re
 CT CGG GAA TCT CAA TGT  CCT AGA AGA AGA ACT CCC TCG CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC  
  R  E  S  Q   S   P   R  R  R   T  P    S  P   R  R   R  R  S   Q  S  P   R   R
         CCT AGA AGA AGA ACT CCC TCG CCT CGC AGA CGC AGA TCT CAA TCG CCG CGT CGC  AGG GCC CTA TAG 
   P   R  R  R   T  P   S  P   R  R   R  R   S  Q   S  P   R   R stop
Ava I
Apa I
       ATG
Start codon
EGFP
co
rekan
EGFP
co
rekan
NLSN
LS
 
Figure 24. Cloning strategy of pEGFP-Core 3C. The cloning strategy of pEGFP-Core 3C was 
performed as described before for pEGFP-Core 2C. The synthetic oligonucleotides consist of 
double HBV core NLS between restriction site Ava I and Apa I.  
 
 
Figure 25. Restriction analysis of 
EGFP-Core 3C clones. 10 clones 
were analyzed by Hind III and Apa I. 
Fragments were separated by 1% 
agarose gel electrophoresis followed 
ethidium bromide staining. Lanes 1, 
8 and 10 show correct digestion 
products in which 2 bands of 661 bp 
and 4702 bp appear. M: DNA 
molecular weight marker 1 kb plus 
DNA ladder. 
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3.4.1.3. EGFP-Core ∆C  
Although not containing NLS, the experiments have shown that marker proteins as 
the EGFP and DsRed are not inert with regard to their nuclear localization. To exclude 
that the core protein backbone without the NLS-comprising C-terminus already affects the 
localization of the fusion proteins, a further expression vector serving as a negative control 
was generated. The expression plasmid, pEGFP-Core ∆C, encodes the EGFP-Core 
fusion protein being C-terminally truncated at amino acid 143 of the core protein. The 
cloning strategy was accomplished by restriction digest of pEGFP-Core 1C with Bsp EI 
and Apa I followed by filling the single stranded part of the resulting sticky ends into blunt 
ends using T4 DNA polymerase and dNTP (see Fig.26). The isolated large fragment was 
purified and ligated. 
 
NLS
(linear)
5130 bp
CMV
Apa I  Bsp EI
CMV
pEGFP-Core ∆C
( 5.130 bp)
CMV
T4 DNA Pol
         &
     dNTP
LIGATION
T4 DNA ligase
589 bp 736 bp
            ATG
Start codon             TAG
Stop codon
kan
C
or
e
EGFP
kan
C
or
e
EGFP
C
or
e
kan
 
Figure 26. Cloning strategy of pEGFP-Core ∆NLS. Plasmid pEGFP-Core 1C was digested with 
Bsp EI and ApaI. The single stranded overlapping ends were converted into double stranded ends 
using T4 DNA polymerase and dNTP. The purified large fragment was self ligated using T4 DNA 
ligase. 
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or
ekan   (
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     (
A.                                      B.CMV CMV
C
or
e
kan
pEGFP-Core 1C
    (5.259 bp)
pEGFP-Core C
    (5.130 bp)
∆
450 bp
381 bp
450 bp
381 bp
 
 
Figure 27. Restriction Map of pEGFP-Core C1 and pEGFP-Core ∆C. A. pEGFP-Core 1C 
digested with Bsp MI generates 4 bands of 381 bp, 450 bp, 1358 bp and 3070 bp. B. pEGFP-Core 
∆C digested with Bsp MI only generates 3 bands of 381 bp, 450 bp and 4299 bp, because the Bsp 
MI site within the C terminus of core is removed.    
 
 
Restriction analysis of the plasmids by Bsp MI showed that 8 out of 13 clones (2, 3, 
4,5,6,7,9 and 11) encode the EGFP-Core ∆C protein, as determined from their cleavage 
products of 381 bp, 450 bp and 4229 bp (see Fig. 27, 28). Clone 1 most likely shows an 
incomplete digest of pEGFP-Core 1C that apparently was still present in the vector 
preparation. 
 
 
   
Figure 28. Restriction analysis of pEGFP-Core ∆C clones. Restriction analysis of 13 clones of 
pEGFP-Core ∆C by Bsp MI. Fragments were separated by 1% agarose gel electrophoresis and 
subsequently stained with ethidium bromide. Lanes 2, 3, 4, 5, 6, 7, 9 and 11 show correct digestion 
products in which 3 bands of 381 bp, 450 bp and 4229 bp appear. M: DNA molecular weight 
marker 1 kb plus DNA ladder. 
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3.4.2. Cloning of EGFP-Core 1, 2, 3 SV40 NLS 
 
To compare the strength of the capsid NLS with a well-characterized NLS, the C-
terminus of the capsid protein domain within the fusion protein was removed and replaced 
by that of the Simian Virus 40 (SV40) large T antigen. To obtain indirect data on the 
affinities of these NLS they were cloned in redundancy in close proximity following the 
idea that if a NLS shows a high affinity it should bind to importin α without diffusing from it. 
In this scenario the close proximity of the other adjacent NLS prevents binding of a 
second importin α molecule so that the NLS redundancy should not have an impact on 
nuclear transport. If the affinity between NLS and importin α is low, importin α can 
dissociate from the NLS but in case of a redundant NLS the probability of an interaction is 
increased. 
   
 
3.4.2.1. EGFP-Core 1 SV40 NLS 
 
The same cloning strategy as for pEGFP-Core 2C was used to generate the 
expression plasmid pEGFP-Core 1 NLS in which the physiological C-terminus of the core 
protein was replaced by the NLS of the SV40 Tag. Plasmid pEGFP-Core 1 C was 
digested with Bsp EI and Apa I. The large DNA fragment of 5123 bp lacking the DNA 
sequence that encodes the C-terminus was isolated. This vector backbone was ligated to 
the double-stranded, 5' phosphorylated oligonucleotide encoding the amino acid 
sequence PKKKRKV (see Fig. 29). This oligonucleotide exposes sticky ends compatible 
with the overhanging ends of the vector. 
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NLS
pEGFP-Core 1C
CMV
Apa I  Bsp EI
CMV
pEGFP-Core 
1 SV40 NLS
( 5.177 bp)
CMV
Ligation
SV4
0
synthetic oligonucleotides
1 SV40 NLS ( 47 bp)
 P  E T  T V V  P K  K K  R K V   stop
589 bp 736 bp
 ATG
   Start codon
                                                                 CCC GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG AGG GCC CTA  TAG 
                                                   P  E   T  T  V  V    P  K   K  K  R  K   V stop
Hind III 
co
re
kan
EGFP
co
re
EGFP
kan
EGFP
co
re
kan
Bsp EI                                                      Apa I
Bsp EI  Apa I
Bsp EI                                                                      Apa I
Bsp EI & Apa I
 
 
 
Figure 29. Cloning strategy of pEGFP-Core 1 SV40 NLS. Plasmid pEGFP-Core was linearized 
using Bsp EI and Apa I. The large linear pEGFP-Core 1C fragment was ligated with a synthetic 
double-stranded oligonucleotide showing Bsp E I and Apa I compatible ends and that encodes the 
NLS of the SV40 Tag.  
 
 
The restriction analysis to identify positive clones was done according to the analysis 
of pEGFP-Core ∆C by using Bsp MI that should not be present in the final plasmids. 
Restriction analysis of the plasmids obtained from 6 clones by Bsp MI showed that all 
transformed clones contained plasmids with the correct restriction pattern of DNA 
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fragments (381 bp, 450 bp and 4346 bp; see Fig. 30). Clone 6 was expanded and the 
plasmid DNA termed pEGFP-Core 1 SV40 NLS was isolated.  
 
    
   
Figure 30. Restriction analysis of pEGFP-Core 1 SV40 NLS. Restriction analysis of 6 clones of 
pEGFP-Core 1 SV40 NLS by Bsp MI. Fragments were separated by 1% agarose gel 
electrophoresis and stained by ethidium bromide. All clones show correct digestion products in 
which 3 bands of 381 bp, 450 bp and 4346 bp appear. M: DNA molecular weight marker 1 kb plus 
DNA ladder.  
 
 
 
3.4.2.2. EGFP-Core 2 SV40 NLS  
 
The same cloning procedure was performed to obtain pEGFP-Core 2 SV40 NLS, 
which has a duplicated SV40 NLS at the C terminus. After digested by Bsp EI and Apa I, 
the linear large fragment of pEGFP-Core 1C was ligated with a synthetic, double stranded 
and phosphorylated oligonucleotide which encodes amino acid sequence PKKKRKV 
PKKKRKV (see Fig. 31). 
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pEGFP-Core 1C
     (linear)
    (5.130 bp)
NLS
CMV
Apa I  
Bsp EI
CMV
SV4
0
synthetic oligonucleotides
2 SV40 NLS ( 68 bp)
 P  E T  T V V  P K  K K  R K  V P  K K  K  R K  V   stop
589 bp 736 bp
 ATG
   Start codon
                                                       CCC GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG  CCT AAG AAG AAG AGA AAG GTG AGG GCC CTA  TAG 
                                                P  E   T  T   V  V    P  K   K  K   R   K  V    P  K  K   K  R   K  V stop
C
or
e
EGFP
EGFP
kan
C
or
e
C
or
e
kan
EGFP
SV
40
CMV
SV40  
Hind III                                      Bsp EI    Apa I
SV40  
Bsp EI                                                                                                       Apa I
Bsp EI                                                                                            Apa I
Bsp EI &  Apa I
pEGFP-Core 1C
    (5.259 bp)
 pEGFP-Core 
  2 SV40 NLS
    (5.198 bp)
   
Figure 31. Cloning strategy of pEGFP-Core 2 SV40 NLS. The same procedure was performed 
with clone  pEGFP-Core 2 SV40 NLS as described before. The synthetic oligonucleotide encodes 
2 SV40 NLS and has artificial restriction site of Bsp EI and Apa I. The ligation product is pEGFP-
Core with 2 SV40 NLS at C terminus. 
 
Restriction analysis of 6 clones showed that all samples are positive clones, which 
generated bands of 381 bp, 450 bp and 4367 bp (see Fig. 32). Clone 6 was expanded 
and used for preparation of plasmid pEGFP-Core 2 SV40 NLS. 
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Figure 32. Restriction analysis of clones of EGFP-Core 2 SV40 NLS. After plasmid preparation, 
the DNAs were digested with enzyme Bsp MI. The fragments were separated on a 1% agarose gel 
and stained by ethidium bromide. All lanes showed bands of 381 bp, 450 bp and 4367 bp. M 
indicated the molecular weight markers 1 kb plus DNA ladder. 
 
 
 
 
3.4.2.3. EGFP-Core 3 SV40 NLS  
 
The same cloning procedure was performed to clone the EGFP-Core 3 SV40 NLS, 
which has a triple SV40 NLS at core C terminus. After digested with Bsp EI and Apa I, the 
linear pEGFP-Core was ligated with synthetic oligonucleotide which encodes amino acid 
sequence PKKKRKV PKKKRKV PKKKRKV (see Fig. 33 for cloning strategy). 
Restriction analysis of the plasmids from the obtained clones by Bsp MI showed that 
with the exception of clone no 2, all plasmids showed the correct restriction pattern, 
generating fragments of 381 bp, 450 bp and 4390 bp (see Fig. 34). Clone no. 6 was 
expanded and used for large scale preparation of plasmid pEGFP-Core 3C. 
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NLS
CMV
Apa I  Bsp EI
CMV
pEGFP-Core 
3 SV40 NLS
( 5.221 bp) 
CMV
Ligation
synthetic oligonucleotides
3 SV40 NLS ( 91 bp)
 P  E T  T V V  P K  K K  R K V  P  K K  K R  K V
Apa I 
 P K  K K  R K V   stop
Bsp EI 
589 bp 736 bp
 ATG
   Start codon
                CCC GAA ACT ACT GTT GTT CCT AAG AAG AAG AGA AAG GTG  AGG GCC CTA  CCT AAG AAG AAG AGA AAG GTG CCT AAG AAG AAG AGA AAG GTG TAG 
              P  E   T  T   V  V   P  K   K  K  R  K   V   P  K   K  K  R  K   V   P  K   K  K  R  K   V stop
pEGFP-Core 1C
    (5.259 bp)
EGFP
pEGFP-Core 1C
      (linear)
    (5.130 bp)
kan
C
or
e
C
or
e
EGFP
kan
EGFP
C
or
e
kan SV4
0
SV40
SV40
Hind III                                     Bsp EI         Apa I
Bsp EI                                                                                                                                   Apa I
SV40  SV40  SV40  
Bsp EI  & Apa I
 
 
Figure 33. Scheme of cloning strategy of pEGFP-Core 3 SV40 NLS. The same procedure was 
performed with clone pEGFP-Core 3 SV40 NLS as described above. The synthetic oligonucleotide 
encodes 3 SV40 NLS and has artificial restriction site of Bsp EI and Apa I. The ligation product is 
pEGFP-Core with 3 SV40 NLS at C terminus.  
 
 
 
Figure 34. Restriction analysis of DNA 
EGFP-Core 3 SV40 NLS. After plasmid 
preparation, the DNAs were digested with 
enzyme Bsp MI. The fragments were separated 
on a 1% agarose gel and stained by ethidium 
bromide. Lanes 1, 3, 4, 5 and 6 showed bands 
of 381 bp, 450 bp and 4390 bp. M indicated the 
molecular weight markers 1 kb plus DNA 
ladder.  
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3.4.3. Intracellular Localization of pEGFP-Core Fusion Protein and its Redundants 
 To determine the localization of the pEGFP-Core fusion proteins with redundant 
capsid and SV40 NLS, all 7 plasmids were transfected into HuH-7 Cells. After fixation, the 
transfected cells were immunostained and, using confocal laser microscopy, the 
localisations of the EGFP fusion proteins were determined. Examples are given in figure 
35. The number of cells with a predominantly nuclear, cytosolic localization or with a more 
or less equal distribution of EGFP fluorescence was quantified (Tab. 5). 
 
 
 
Figure 35 (part one). For legend see next page. 
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Figure 35. Localisation of EGFP-Core ∆C, 
1C, 2C, 3C and EGFP-Core 1, 2, 3 SV40 NLS 
in HuH-7 cells. All fusion proteins were either 
found predominantly in the cytoplasm (upper 
row) or in the nucleus (middle row) or in rare 
cases in both cytoplasm and nucleus (lower 
row) but with a different frequency (see Tab. 5). 
EGFP-Core fusion proteins are indicated by the 
green fluorescence, nuclear pore complexes 
are depicted as red rings. All transfections were 
done in parallel.  
The quantification as depicted in table 5 
showed that all fusion proteins exposing an 
NLS showed a higher ratio of nuclear 
EGFP than the control lacking the C-
terminus. Redundancy of the HBV capsid 
NLS increased the transport competence 
from 75% nuclear capsids (1C) to 94% 
(3C). According to the divergence of the 
assays determined before, this difference 
seems to be significant. The import 
competence of the fusion protein EGFP-
Core 2C is in between EGFP-Core 1C and 
EGFP-Core 3C. Redundancy of EGFP-
Core fusion proteins harbouring the SV40 
Tag NLSs showed an increasing transport 
competence correlated with redundancy of 
the NLS. However, this increase is not as 
high as observed for the capsid NLS and 
thus are possibly not significant. 
The observation that redundancies of 
the NLS increase the rate of nuclear fusion 
protein to some extent indicates that both 
NLS allow the dissociation from importin 
α. Thus not only the probability of an 
importin α-NLS contact determines the 
nuclear import rate but the affinity between 
these binding partners. The dissociation 
from importin α is in accordance with the 
hypothesis of Schwöbel and Moore (2000) 
who speculated that an NLS must not be 
too strong in order to allow dissociation of 
cargo and import receptors within the 
nuclear basket. Comparing the import 
mediated   by  HBV  capsid  NLS   and  the  
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SV40 Tag NLS both NLS have the same transport capacity indicating that the affinity 
between importin α and the NLS is similar.  
expressed protein cytoplasm Nucleus both total 
EGFP-Core ∆C 29 23 1 53 
  55% 43% 2% 100% 
EGFP-Core 1C 5 15 0 20 
  25% 75% 0% 100% 
EGFP-Core 2C 2 9 0 11 
  18% 82% 0% 100% 
EGFP-Core 3C 2 33 0 35 
  6% 94% 0% 100% 
EGFP-Core 1 SV40 NLS 40 135 0 175 
  23% 77% 0% 100% 
EGFP-Core 2 SV40 NLS 19 75 0 94 
  20% 80% 0% 100% 
EGFP-Core 3 SV40 NLS 9 74 1 84 
  11% 88% 1% 100% 
Table 6. Distribution of EGFP-Core ∆C, 1C, 2C, 3C and of EGFP-Core 1, 2, 3 SV40 NLS fusion 
proteins in HuH-7 cells. The different EGFP-Core fusion proteins were transfected in parallel. 
EGFP-Core ∆C serves as a negative control. The other fusion proteins either contain the natural 
HBV capsid NLS alone or in redundancy (EGFP-Core 1C, 2C, 3C) or the C-terminus downstream 
amino acid 143 was replaced by the NLS of  the  SV40 Tag as single, double or triple (EGFP-Core 
1, 2, 3 SV40 NLS).  
 
3.5. Effect of Staurosporine on the Localization of EGFP-Core 3 C and 3 SV40 NLS  
The HBV capsid protein of the used isolate contains seven phosphorylation sites 
within the C-terminus comprising amino acids 140-183. One additional phosphorylation 
site is found upstream of the C-terminus in the flexible linker region at amino acid 139. 
The degree of phosphorylation, the responsible protein kinase, the used phosphorylation 
sites and the time point of phosphorylation are not fully understood yet. Phosphorylation at 
Serine residue 157 is required for pregenome packaging and the residues 164 and 170 
are essential for polymerase activity (Gazina et al., 2000; Melegari et al., 2005). Moreover, 
serine 170 and/or 172 is phosphorylated in capsids from virions (Machida et al., 1991). 
Some phosphorylation at a non-specified site is essential for nuclear import of the capsids 
(Kann et al., 1999). However, for entire HBV capsids it is unclear whether the 
phosphate(s) within the C-terminus is/are required to allow NLS-importin α-interaction or 
whether phosphorylation induces a structural change that leads to the exposure of the 
NLS on the capsid surface. Unpublished studies using FITC-BSA-HBV capsid NLS 
conjugates revealed that phosphorylation within the NLS inhibits the transport capacity of 
the conjugate (A. Vlachou and M. Kann, pers. communication). However, for the SV40 
Tag it was shown that a phosphate directly adjacent to the NLS has a negative effect on 
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nuclear import while phosphorylation at sites further upstream enhances NLS function 
(Jans, 1995; Hübner et al., 1997; Jans and Jans, 1994).  
In order to analyse the effect of phosphorylation on nuclear transport of the EGFP-
Core fusion proteins, cells were treated with a broad-range protein kinase inhibitor after 
transfection. EGFP-core 3C was used since this protein shows the strongest nuclear 
localisation thus allowing the best differentiation in case that inhibition of phosphorylation 
prevents  nuclear  import.  As a  control  EGFP-Core 3 SV40 NLS  was used lacking the 
C-terminus and the phosphorylation sites downstream of amino acid 143. 
       EGFP        NPC        merge 
       
Figure 36. Localization of EGFP-Core 1C in HuH-7 
cells treated with Staurosporine. EGFP-Core 3C and 
3 SV40 NLS fusion proteins localized in the cytoplasm 
(uuper row) or in nucleus (lower row). Their presence is 
indicated by the green fluorescence. The nuclear pore 
complexes are shown as red rim-like stains. 
Transient expression revealed that 
the cytoplasmic and the nuclear 
appearance of both fusion proteins 
looked identical (Fig. 36) to their 
expression in untreated cells (Fig. 
35). In all compartments the 
fluorescences looked condensed in 
some areas being more pronounced 
in the cytoplasm. Despite of low 
transfection efficiency, quantification 
of nuclear and cytoplasmic 
localisation in different cells 
however showed a dramatically 
changed localization (Tab. 6) in that 
the vast majority of fusion proteins 
were found within the cytoplasm. 
This changed distribution is in 
striking difference to EGFP that 
shows an unchanged localization 
pattern. 
 
The only core protein phosphorylation site present in both fusion proteins is located 
at amino acid 141. In the SV40 Tag NLS no phosphorylation site is present. Assuming 
that the dramatic changes in the distribution pattern is caused by an inhibited 
phosphorylation of the core protein, one must conclude that this site has an essential 
function in the viral life cycle in that its phosphorylation is important for allowing the NLS 
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function. However, Staurosporine may have had additional effects. It prevents cell division 
so that passive trapping of proteins is inhibited.  
 
protein staurosporine cytoplasm nucleus both total 
EGFP-Core 3 C no 2 33 0 35 
    6% 94% 0% 100% 
  yes 13 0 0 13 
    100% 0% 0% 100% 
EGFP-Core 3 SV40 no 1 18 0 19 
   6% 94% 0% 100% 
  yes 32 0 0 32 
    100% 0% 0% 100% 
EGFP no 18 5 0 23 
   78% 28% 0% 100% 
  yes 19 6 0 25 
    76% 24% 0% 100% 
 
Table 7. Distribution of EGFP, EGFP-Core 3C and pEGFP-Core 3 SV40 NLS in Staurosporine 
treated HuH-7 cells. Without Staurosporine EGFP-Core 3C and 3 SV40 NLS predominantly 
localized within the nucleus. Staurosporine treatment changed the distribution pattern in that the 
cells exclusively show a cytoplasmic localization of the fusion proteins. In contrast, localization of 
EGFP was not affected. 
  
 
3.6. Effect of FCS on Intracellular Localization of EGFP-Core Fusion Proteins 
 
3.6.1. Effect of FCS on Cell Division 
 
To differentiate whether cell division (or related phenomena) or fusion protein 
phosphorylation effects nuclear localization, HuH-7 cells were grown in the presence of 
2.5 and 10% FCS. In parallel to transfections with pEGFP-Core 3 SV40 NLS the cells 
were harvested and counted after seeding and at the time of fixation. The numbers of 
cells are given in Table 7. 
FCS concentration Start Cell Number End Cell Number
2,5% 7,12 x 105 1,37 x 107 
10% 7,12 x 105 1,65 x 107 
Table 8. Cell division of HuH-7 cells at different FCS concentrations. 
 
After 48 hours the number of cells differed only marginally. This observation is in 
accordance with the established phenomenon that HuH-7 cells cannot be arrested even in 
the absence of FCS. 
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3.6.2. Effect of Serum on the Localization of EGFP-Core 3 SV40 NLS in HuH-7 Cells 
Visualization of EGFP-Core 3 SV40 NLS showed a significant effect caused by 
serum (see Fig. 37 and Tab. 8). While at 10% FCS only half of the cells showed a nuclear 
localization, all cells being grown at low serum concentrations showed a nuclear 
localization of the fusion protein. 
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Figure 37. Fluorescence of EGFP-Core 3 
SV40 NLS in HuH-7 cells at different FCS 
concentrations. EGFP-Core 3 SV40 NLS 
fusion protein at 2.5% FCS found only 
localized in the nucleus, whereas at 10% 
FCS, it localized in cytoplasm (upper row), 
nucleus (middle row) and both compartments 
(lower row). The presence of EGFP-Core 
fusion proteins is indicated by the green 
fluorescence. The nuclear pore complexes 
are shown as red rim-like stains. 
 
 
 
FCS cytoplasm nucleus both total
2.5% 0 17 0 17 
 0% 100% 0% 100%
10% 14 16 1 31 
  45% 52% 3% 100%
 
Table 9. Quantification of intracellular 
localization of EGFP-Core 3 SV40 NLS in 
HuH-7 cells in the presence of different 
FCS concentrations. At the low 
concentration of FCS EGFP-Core 3 SV40 
NLS localizes only in the nucleus. The higher 
concentration of FCS decreased a number of 
nuclear localization to 52%. 
 
Apparently not cell division but serum concentration in the medium had an impact on 
nuclear import capacity of the fusion protein. It must be thus concluded that the inhibitory 
effect of Staurosporine may have been caused by its suppression of mitosis and not 
necessarily by its inhibition of core protein phosphorylation. Considering that growth 
factors generally induce protein kinases as e.g. the Ras-MEK-Erk cascade this result is 
nonetheless surprising because here - in contrast to the Staurosporine experiments - 
phosphorylation has a negative effect on nuclear transport. However, as for the SV40 Tag 
different phosphorylation sites with different effects may have been used. 
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3.7. Nuclear Localization of EGFP-Core Fusion Proteins in HepG2 Cells 
 
If phosphorylation of the fusion proteins plays a crucial role for nuclear import of the 
fusion proteins one can expect that nuclear localization depends upon the cell line in 
which the proteins are expressed. Thus I analyzed the distribution of NLS-containing 
fusion proteins in another hepatoma cell line (HepG2 cells). HepG2 cells divide less 
rapidly than HuH-7 cells as shown in table 9.  The transfection was done as described for 
 
FCS concentration Start Cell Number End Cell Number
2,5% 2,19 x 106 6,12 x 106 
10% 2,19 x 106 8,64 x 106 
 
Table 10. Cell division of HepG2 cells in different FCS   
                 concentration 
HuH-7 cells in the presence of 
both 2.5% and 10%  FCS.  
Localisation of the fusion 
proteins  is  shown  in  Fig.  38,  
and their distribution is depicted
in table 10. The nuclear fluorescence appeared to be different  to that observed for  HuH-7 
cells.  While HuH-7 cells showed a defined  enrichment of the fusion proteins,  HepG2  
nuclei  showed fluorescence within the entire karyoplasm with the exception of some 
spots looking similar to nucleoli.  
Like for the HuH-7 cells there was an observable but relatively poor impact of the 
NLS redundancy. However, strikingly different the SV40 Tag mediated a much stronger 
nuclear localization than the capsid NLS that showed a poor transport capacity in 
comparison to its strength in HuH-7 cells. In addition both NLS were unaffected by the 
serum concentration in the medium. 
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expressed protein cytoplasm nucleus both total 
EGFP-Core no NLS 28 4 0 32 
          (2,5% FCS) 87% 13% 0% 100% 
EGFP-Core no NLS 15 2 0 17 
          (10% FCS) 88% 12% 0% 100% 
EGFP-Core 1C NLS 18 2 0 20 
(2,5% FCS) 90% 10% 0% 100% 
EGFP-Core 1C NLS 23 4 0 27 
(10% FCS) 85% 15% 0% 100% 
EGFP-Core 2C NLS 26 6 0 32 
(2,5% FCS) 81% 19% 0% 100% 
EGFP-Core 2C NLS 14 3 0 17 
(10% FCS) 82% 18% 0% 100% 
EGFP-Core 3C NLS 25 6 0 31 
(2,5% FCS) 80% 20% 0% 100% 
EGFP-Core 3C NLS 14 4 0 18 
(10% FCS) 78% 22% 0% 100% 
EGFP-Core 1 SV40 NLS 22 26 0 48 
(2,5% FCS) 46% 54% 0% 100% 
EGFP-Core 1 SV40 NLS 9 9 0 18 
(10% FCS) 50% 50% 0% 100% 
EGFP-Core 2 SV40 NLS 15 28 0 43 
(2,5% FCS) 35% 65% 0% 100% 
EGFP-Core 2 SV40 NLS 16 18 0 34 
(10% FCS) 47% 53% 0% 100% 
EGFP-Core 3 SV40 NLS 16 31 0 47 
(2,5% FCS) 34% 66% 0% 100% 
EGFP-Core 3 SV40 NLS 12 20 0 32 
(10% FCS) 38% 62% 0% 100% 
Table 11.  Frequency of the different fusion protein localizations in HepG2 cells. While the 
fusion protein without NLS localized like in the HuH-7 cells and independent upon serum 
concentration the distribution of the other EGFP-Core fusion proteins strongly differed from to that 
in HuH-7 cells. 
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Figure 38. Localization of EGFP-Core 1C, 2C, 
3C and EGFP-Core  2, 3 SV40 NLS in HepG2 
cells.  The fusion protein localized in cytoplasm 
(upper row), nucleus (middle row) and both 
cytoplasm and nucleus (lower row) in EGFP-
Core 1C and 2 SV40 NLS.  In EGFP-Core 2C, 
3C and 3 SV40 NLS localized only in cytoplasm 
(upper row), nucleus (upper row). The fusion 
proteins are shown as green fluorescence, the 
nuclear pore complexes in red. 
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3.8.  Dimerization of EGFP-Core 1C 
 
 As expected redundancy of NLS increased nuclear localization of the fusion 
proteins. However in all the experiments it remained unclear whether the fusion proteins 
were transported as mono- or dimers. For analysis of dimerization EGFP-Core 1C was 
transiently expressed in HepG2.2.15 cells that stably express HBV including the viral 
capsid. The successful transfections were determined by estimating the number of green 
fluorescing cells. The cells were lysed and the soluble proteins were subjected to a 
phosphorylation using [γ32P]ATP. This kind of labelling was required since antibodies 
against the capsid protein monomer react only poorly, requiring large amount of protein. 
The radioactively labelled lysate was used for immune precipitations with biomagnetic 
beads. In a control precipitation the beads were coated with the same anti capsid antibody 
that was used for indirect immune fluorescence before. According to experiments of 
others (Kann, unpublished) this antibody recognizes conformational epitopes on two 
neighboring core protein dimers. For the second precipitation the beads were coated with 
an anti EGFP antibody. These antibody-coated beads were subjected to immune 
precipitation of the lysates. 
 
Figure 39. Immune precipitation of capsid proteins and 
fusion proteins with an anti-capsid antibody and an anti 
EGFP antibody. Proteins were phosphorylated with 32P prior 
to precipitation. The figure shows the phosphoimager scan 
after separation by SDS PAGE. HBV capsid protein appears 
as a 21.5 kDa band, EGFP-Core 1C as a 48.5 kDa band. M: 
14C-labelled protein molecular weight marker; 1: Anti capsid 
antibody precipitated core protein from EGFP-Core 1C 
transfected HepG2.2.15 cells; 2: Anti EGFP antibody 
precipitated core and EGFP-core fusion protein from EGFP-
Core 1C transfected HepG2.2.15 cells. 
The precipitated proteins were 
separated by SDS PAGE and 
radioactive core proteins were 
visualized by phosphoimaging. 
Figure 39 shows that the anti 
capsid antibody precipitated 
the core protein from 
HepG2.2.15 cells. In this 
precipitation, no EGFP-Core 
fusion protein was 
precipitated, indicating that the 
fusion protein does not 
become incorporated into 
capsids. The anti EGFP 
antibody however precipitated 
not only the fusion protein but 
the wild-type capsid protein 
indicating that the fusion 
protein at least dimerizes. 
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3.9. Effect of the Assembly Inhibitor Bayer 41-4109 on the Localization of EGFP  
       Core Fusion Proteins 
 
Recently, an assembly inhibitor of HBV capsids was found (Deres et al., 2003). This 
inhibitor interacts with capsid formation. However, the site of interaction and the stage at 
which assembly is blocked - dimerization of the capsid protein monomers or the 
trimerization of the dimers - is yet unclear.  
First the HBV genome was transfected into HuH-7 cells as described before. Twenty 
four hours after transfection, the inhibitor was added to one sample whereas a second 
one remained untreated. The successful inhibitor treatment was determined by real time 
PCR. Supernatant of cell culture was analyzed 48 hours post transfection. 
Unencapsidated viral DNA, as it may be have been derived from transfected genomes 
sticking to the dish or from lysed cells, was degraded prior to purification of viral DNA . 
Real time PCR was done in triplets showing the addition of the inhibitor reduced the 
number of encapsidated viral genomes to 60%. This inhibition rate was significantly 
smaller than the one published for HepG2.2.15 cells in which virus secretion was reduced 
six fold (Deres et al., 2003). This difference may either mean that the cell type or may play 
a role, for instance that HuH-7 can export the inhibitor more efficiently than HeG2 cells. 
However, since the transfected HBV genome is genotype A and HepG2.2.15 cells 
express HBV of genotype D a genotype-specific binding of the inhibitor could not be 
excluded. 
Next the effect of the inhibitor on localization of the fusion proteins was investigated. 
The experimental procedure was done as described before but the inhibitor was added 
after over night incubation following transfection. NPCs were stained after further 24 hours 
of incubation. 
Figure 40 and 41 showed a changed distribution pattern within the nucleus. In 
contrast enrichment in defined areas the nuclear fluorescence filled the entire karyoplasm 
with the exception of some nucleoli-shaped areas.  
When quantifying the number of cells with cytoplasmic or nuclear fluorescence (Tab. 
11) a striking difference for the EGFP-core fusion proteins compared to capsid localization 
was observed. While EGFP-core 1C showed a nuclear localization in 52% of the 
untreated cells, Bayer 41-4109 treated cells showed a nuclear localization in only 11%. 
The same ratio or even more pronounced was observed for EGFP-Core 3C (57% versus 
4%). 
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Figure 40.  Localization of EGFP-Core 1C 
and 3C in Bayer 41-4109-treated HuH-7 cells. 
EGFP-Core 1C fusion proteins localized either 
in the cytoplasm (upper row), the nucleus 
(middle row) or in both compartments (lower 
row). EGFP-Core 3C fusion protein localized 
only in the cytoplasm (upper row) and nucleus 
(lower row). EGFP-Core fusion proteins are 
shown in green, the nuclear pore complexes in 
red. 
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Figure 41.  Localization of EGFP-Core 1 and 3 
SV40 NLS in Bay 41-4109-treated HuH-7 cells. 
EGFP-Core fusion proteins localized either in the 
cytoplasm (upper row) or in the nucleus (lower 
row). EGFP-Core fusion protein is shown in 
green, the nuclear pore complexes in red. 
 
 
Apparently, dimerization increases the nuclear transport capacity of the fusion 
proteins. The effect of dimerization was much more pronounced when adding an 
additional NLS to the fusion protein. In contrast, the effect of the inhibitor on EGFP-Core 
SV40 NLS protein localization was not significant. Although the percentage of cells with 
cytoplasmic fluorescence increased in the inhibitor treated cells for both EGFP-Core 1 
SV40 NLS and EGFP-Core 3 SV40 NLS, this difference was only marginal and with 10% 
not above the variation occurring between different transfections. The difference between 
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the EGFP-Core 1, 3C and EGFP-Core 1, 3 SV40 NLS may imply that the inhibitor 
interacts with the C-terminus of the capsid protein preventing binding of importin α to the 
NLS. This area overlaps with the nucleic acid binding domain (Hatton et al., 1992) of the 
capsid protein that stabilizes the capsid. As it was shown previously for DHBV capsids, 
mutations within this domain destabilize the viral capsid. It must be thus assumed that the 
described effect on capsid formation by Deres et al., (2003) is not necessarily a direct 
inhibition of assembly but may cause a reduced stability.  
 
expressed protein inhibitor cytoplasm nucleus both total 
EGFP-Core 1C No 33 36 0 69 
    48% 52% 0% 100% 
  Bayer 41-4109 82 10 1 93 
    88% 11% 1% 100% 
EGFP-Core 3C No 33 44 1 78 
   42% 57% 1% 100% 
  Bayer 41-4109 86 4 0 90 
    96% 4% 0% 100% 
EGFP-Core 1 SV-40 NLS No 19 75 0 94 
   20% 80% 0% 100% 
  Bayer 41-4109 23 57 0 80 
    29% 71% 0% 100% 
EGFP-Core 3 SV-40 NLS No 9 74 1 84 
   11% 88% 1% 100% 
  Bayer 41-4109 21 79 0 100 
    21% 79% 0% 100% 
 
Table 12. Localization of  EGFP-Core 1C, 3C and EGFP-Core 1, 3 SV40 NLS fusion protein 
       in Bayer 41-4109-treated and untreated HuH-7 cells. 
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4. Discussion 
 
4.1. Nuclear Localization of HBV Capsids After Transfection of the Entire HBV     
       Genome into HuH-7 Cells 
 
Upon infection with the human hepatitis B virus (HBV), the capsid or core particle 
predominantly localizes in the nuclei of the hepatocytes (Serinoz, 2003). Only in highly 
active infections, which result in high virus titers in the serum, capsids are found within the 
cytoplasm (Sansonno et al., 1988). Apparently, these phenomena are intrinsic to HBV 
since expression of the capsid in heterologous systems as in transgenic mice, results in 
the same distribution pattern (Guidotti et al., 1995). The nuclear localization is 
independent upon other viral gene products. Rabe et al. (2003) showed that in in vitro 
transport systems the capsids become imported into the nucleus. This import is 
associated with the release of the encapsidated viral genome into the karyoplasm, which 
is essential for the viral life cycle. In mice transgenic for the core protein, cytoplasmic 
capsid stain could only be observed in those cells that have recently undergone cell 
division. This observation was interpreted in that the nuclear membrane is impermeable 
for the entire capsid (Guidotti et al., 1994). Accordingly the diameter of the capsid being 
either 32 or 36 nm dependent upon the symmetry (Crowther et al., 1994) is close to the 
maximal functional diameter of the nuclear pore 30-40 nm (Newmeyer and Forbes, 1988; 
Akey, 1995) and far above the diffusion limit of FITC-dextran fluorescence labeled 
macromolecule lacks NLS of ~77 kDa (Kastrup et al., 2005). It must be thus assumed that 
the non-assembled proteins or assembly intermediates enter the karyoplasm and not the 
fully assembled capsids. Following this hypothesis the finding of assembled nuclear 
capsids as they can be visualized by electron microscopy (Furuta et al., 1975) can be 
explained by an intranuclear assembly of the subunits. Consistently, subunit expression 
leads to form capsids in the absence of other viral gene products after reaching a 
threshold concentration (Ceres and Zlotnick, 2002). 
The single protein species out of which the capsids consists has a molecular weight 
of 21.5 kDa. This size would allow a passive entry into the nucleus by diffusion. However, 
even smaller karyophilic proteins as e.g. histones (Jäkel et al., 1999) with a MW of 14.3 to 
39 kDa enter the karyoplasm by active transport. 
The import of HBV capsid is mediated by the nuclear transport receptors importin α 
and ß. For binding to the importin α (Kann et al., 1999) a nuclear localization signal (NLS) 
must be exposed. The function of the NLS is influenced by phosphorylation of serine 
residues within the core protein (Vlachou Ph.D thesis, 1999). There are seven potential 
phosphorylation sites present in the core protein located at amino acids S-157, S-164, S-
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170, S-172, S-178, S-180 and S-183 but there are only limited data on the extent of 
phosphorylation and on the sites that are used. Phosphorylation is required for NLS 
exposure and function (Kann et al., 1999) but the phosphate must not be added to the 
serine residue (aa 162) within the NLS (Vlachou Ph.D thesis, 1999). A phosphorylation 
site that is used localizes at serine residue aa 157 since its phosphorylation is required for 
packaging of the RNA pregenome -polymerase complex. The sites at amino acid 170 
and/or 172 seem to become phosphorylated in vivo, as determined with phospho-site 
specific antibodies in virions (Machida et al., 1991) and S-164 and S-171 are required for 
polymerase activity (Melegari et al., 2005). 
To allow these modifications it was required to analyze the nuclear import of the core 
protein in living cells instead of using in vitro transport assays. Consequently, the 
localization of the core protein was analyzed after expression in a human hepatoma cell 
line (HuH-7). This cell line expresses and secretes HBV at the level of a chronically HBV-
infected individual after transfection with the viral genome. It was thus assumed that all 
modifications required for the viral life cycle occur. In fact, the evaluation of this system by 
expressing all viral gene products in the present work showed a predominantly nuclear 
localization of capsids similar to that observed in vivo. However, in 26% of the cells - more 
than normally found in chronic HBV carriers - the capsids remained in the cytosol. This 
phenomenon can be linked to cell division as nuclear core protein (or capsid-) localization 
does not occur in S phase (Yeh et al., 1993) and is linked to high viral load in patient sera 
(Naito et al., 1994). 
 
4.2. Structure of the Fusion Proteins 
Investigation of the core protein transport is complicated by its ability to assemble. 
To exclude these partially unpredictable structural changes the core protein was 
expressed as a fusion protein that was linked at its N terminus with the enhanced green 
fluorescent protein (EGFP). The fluorescent marker protein EGFP, which has a molecular 
weight of 27 kDa has been chosen because own experiments in HuH-7 cells revealed a 
weaker affinity to the nucleus than observed for an alternative marker protein DsRed. This 
was surprising because DsRed has a higher molecular weight (89 kDa) due to its 
tetramerization (Yarbrough et al., 2001) and should thus diffuse through the nuclear pores 
to a lower extent. However, since both proteins only showed a very low number of cells 
with an equal distribution in cytoplasm and nucleus (0 to 2%) it must be concluded that 
diffusion only plays a minor role in the distribution anyway and that the marker proteins 
become passively trapped inside the nuclei upon mitosis. 
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Figure. 42. Dimer of HBV capsid  and its dimer packing in T=4 capsid.  
a. Two orthogonal views of the HBV capsid dimer (subunit C and D) cys-61 which forms a disulfide 
bridge between the two monomers, is shown in green and cys-48 which does not form disulfides in 
yellow (Wynne et al., 1999). b. The arrangement of the four independent subunit in the T= 4 capsid 
showing one icosahedral face (Zlotnick et al., 1996). c. The HBV capsid viewed down an 
icosahedral three-fold axis. d. Packing of the dimers in the T=4 capsid in the region of a quasi three 
fold axis. Subunits A,B,C and D are shown in green, yellow, red and blue as in Böttcher et al. 
(1997).   
 
N terminal fusions at the core protein are known to prevent capsid formation once 
exceeding a size limit of 40 amino acids as it was shown by Koletzki et al. (1999) who 
inserted parts of the Puumala hantavirus nucleocapsid protein. In fact these data could be 
confirmed in the present work in that the fusion proteins failed to become incorporated into 
capsid although – nonetheless – preserved their interaction with wild type core protein. 
This was not unexpected since the dimerization is mediated by the association of two α-
helices in the center of the core proteins (see fig. 42) while the N-terminal arm of each 
monomer packs against the opposing subunit. Even a trimerization of the dimers, which is 
the next higher ordered structure in capsid assembly is likely since it involves contact of 
the dimers at aa 128 to 136 (Wynne et al., 1999).  
As reported that redundancy of NLSs increases the nuclear transport competence of 
karyophilic proteins and complexes (Ludtke et al., 1999), the dimerization or subsequent 
trimerization of the dimers should have an impact on the nuclear translocation of the 
fusion proteins. This assumption was proven in the present work since the addition of 
Bayer 41-4109, an assembly inhibitor of the HBV capsid (Dienes et al., 1995), reduced the 
number of cells with nuclear fusion proteins with HBV NLSs drastically to one fourth. 
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4.3. Localization in HuH-7 Cells 
4.3.1. Transport Competence of EGFP-Core Fusion Proteins 
Different EGFP core fusion protein vectors were cloned and the encoding fusion 
proteins were expressed. To evaluate the strength of the HBV core NLS the C terminus 
exhibiting this signal (158-PRRTPSPRRR-168) was replaced by the NLS of the SV40 Tag 
(PKKKRKV) that shows a similar positive charge. The SV40 Tag NLS mediated a more or 
less similar proportion of nuclear fusion proteins in HuH-7 cells than the HBV core NLS, 
indicating a comparable affinity of importin α. This finding was surprising since the HBV 
capsid NLS does not show the consensus sequence (K(K/R)x-(K/R) namely in that the 
HBV NLS does not contain a K residue. Based on crystallography of importin α with NLS 
of Lamin B2 and SV40 Tag the longer side chain of the arginine residue, as in the HBV 
sequence, should not fit into the binding pocket P2 of the importin. However, as described 
in the result section there may be additional sites outside the NLS that interact with the 
importin α, stabilizing the binding as it was suggested for other proteins as the Borna virus 
p10 protein (Wolff et al., 2002) and SV40 Tag (Harreman, 2004). 
In all transfections a significant proportion of fusion proteins stayed in the cytoplasm. 
As indicated by the low numbers of cells showing a distribution in both compartments of 
cytoplasm and nucleus, EGFP-Core fusion proteins are not diffusing throughout the cell. It 
must be thus concluded that cells with cytosolic fusion protein localization differ from 
those cells that allow nuclear import. One possibility might be a generally reduced nuclear 
import capacity of nuclei in dividing cells, as it was observed recently by others (Kann, 
unpublished) or that signal cascades that become changed upon cell division modify the 
fusion proteins e.g. by phosphorylation to reduce their import competence. 
To get evidence for the effect of NLS redundancies, the HBV core NLS and the 
SV40 Tag NLS were fused to the EGFP core proteins in doublets or triplets. The second 
core NLS was separated from the first original one by 18 amino acids; the third NLS was 
separated from the second NLS by 8 amino acids. The sequences between the NLSs 
represent the natural primary amino acid sequence of the core protein C terminus. In 
contrast the second and third SV40 Tag NLS were directly fused with first or second SV40 
Tag NLS, respectively. At least for the latter proteins it must be assumed that it is 
sterically impossible that more than one importin α/ß-complexes that has a molecular 
weight of 153 kDa can bind per fusion protein. 
In all fusion proteins redundancy increased nuclear import to a comparable extent. 
Apparently, the spacers between the core protein NLSs did not allow binding of additional 
import receptors as it was assumed for the fusion proteins with the SV40 Tag NLS. The 
increase of transport competence thus indicates a higher probability that the transport 
70
 
Discussion 
_________________________________________________________________________ 
receptors interact with the NLS on a single fusion protein molecule. The hypothesis that 
multiple NLS increase the nuclear import reaction was supported by the observation that 
preventing dimerization by Bayer 41-4109 reduces the transport capacity of all fusion 
proteins. 
 
4.3.2.  Effect of Cell Cycle and Phosphorylation 
As mentioned above the cell cycle may have had an impact on nuclear localization. 
The cell lines used in this work however did not allow synchronisation by serum starving. 
Nonetheless, the serum concentrations in the culture medium had a strong effect on 
localization in HuH-7 cells in that higher concentrations result in a more cytosolic 
localization. Since cell division was not significantly different is must be concluded that the 
signal cascades induced by growth factors in the serum mediated this effect. Although 
one may speculate that phosphorylation of the fusion proteins might have been the 
effector pathway, increasing serum concentrations may have other reasons as e.g. an 
effect on the nuclear transport capacity of the nuclear pore, as it was observed recently 
(Kann, unpublished). 
 The effect of phosphorylation was further investigated by treating transfected cells 
with Staurosporine. Staurosporine is an inhibitor predominantly of the protein kinase C 
(PKC) isoforms (Tamaoki et al., 1986). Targeting PKC was particularly interesting since 
other have shown that this kinase becomes encapsidated in capsids (Kann et al., 1993). 
Surprisingly, Staurosporine treatment had a dramatic effect on the localization of both 
types of fusion proteins - irrespectively whether they comprised the HBV core or the SV40 
Tag NLS - in that inhibition of phosphorylation led to an exclusive cytoplasmic localization. 
As the transport receptors and the proteins of the nuclear pore are according to the 
current knowledge, not modified by phosphorylation the inhibition must have been 
affected the EGFP fusion proteins. 
As the changed localization was observed as well with the fusion protein EGFP-Core 
3 SV40 Tag NLS that exhibits only one of the potential core protein phosphate acceptor 
sites, it must be concluded that this serine residue at position 141 apparently plays a 
crucial role in nuclear transport of the HBV core protein. Although there is no experimental 
evidence on primary sequence analysis yet, Kann et al., 1993 revealed that this site 
represents a target site for PKC. 
The observation that there are less cytoplasmic fusion proteins than in the EGFP-
expressing untreated HuH-7 cells indicates that there was less passive trapping of the 
fusion proteins during mitosis. In fact, this assumption is supported by the observation that 
Staurosporine prevents cell division ( Hofmann et al., 1988).  
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4.4. Localization in HepG2 Cells 
The observation that cell culture conditions – maybe via phosphorylation – an effect 
the localization of the fusion proteins resulted in the investigation of another hepatoma cell 
line. HepG2 cells to not divide as rapidly as HuH-7 cells but like the HuH-7 cell line, they 
generate hepatitis B virions after transfection of the genome (Sells et al., 1988). 
Transfection of the fusion protein-encoding vectors led to a reduced number of successful 
transfections compared to HuH-7 cells. This was expected since the entry of the DNA 
plasmids into the nucleus depends upon mitosis. Due to the low number of fusion protein-
positive cells the interpretations have to be taken with care. Nevertheless, as for the HuH-
7 cells, redundancy of the NLS increased the proportion of cells with a predominantly 
nuclear localization. However, in HepG2 cells the SV40 Tag NLS showed a significantly 
higher nuclear import capacity than the HBV core protein NLS. 
To evaluate the role of serum on the localization of the fusion proteins, EGFP-Core 
fusion proteins were expressed parallel in HepG2 cells that were incubated at the same 
serum concentrations as the HuH-7 cells. In HepG2 cells however, the serum had no 
effect on fusion protein localization. This observation strongly argues against that the 
inhibited nuclear import is caused by a generally reduced transport competence in the 
presence of higher amounts of growth factors. It supports that both cells have a different 
phosphorylation pattern. May be HepG2 cells allow less phosphorylation at serine residue 
141 resulting in a reduced import of all fusion proteins. However, the responsible protein 
kinase is apparently uneffected by the serum level. 
  
4.5. Molecular Implications for the Nuclear Import and the Viral Life Cycle 
Taken together, the presented data show that the HBV capsid protein shows 
transport competence. To allow significant nuclear import however the NLS has to be 
exposed in redundancy. Only when exposed on different protein molecules high import 
rates occur being comparable to the prototype NLS of the SV40 Tag. Multimerizing the 
HBV NLS increases nuclear import but cannot fully compensate, implying that it is neither 
the affinity of importin α to the NLS nor the probability of a NLS-importin α interaction that 
restricts nuclear import reaction. More than one importin α/ß complex should be bound 
per import complex. In conclusion it must be thus assumed that the capsid should be 
already partially assembled to be transported into the nucleus. 
Regardless of these interpretations, phosphorylation of the core protein has an 
important effect on the nuclear import of the core protein. For the viral life cycle this 
observation is conclusive: Phosphorylation at S-157 is required for encapsidation of the 
pregenomic mRNA (Gazina et al., 2000), and phosphorylation at S-164 and S-170 are 
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essential for reverse transcription (Melegari et al., 2005). The function of the NLS is thus 
correlated with genome maturation and S-141 as shown in this work - appears to be 
essential as well. The observation however that S-164 should not be phosphorylated for 
the NLS function (Vlachou Ph.D thesis, 1999) implies that a dephosphorylation must occur 
after reverse transcription.  
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5. Summary 
 
HBV core particles are involved in a number of important functions in the replication 
cycle of HBV. Nuclear import studies of cellular protein showed that HBV capsid binds to 
the nuclear pore complex, following the classical pathway of karyophilic proteins, which is 
mediated by the cellular proteins importin α and β. The transport of the capsid into the 
nucleus is facilitated by a nuclear localization signal that is located within the carboxyl 
terminal domain between amino acid 158 and 168 of the core protein. Unlike the NLS 
consensus sequence, HBV core NLS does not comprise a lysine residue, leading to the 
assumption that the NLS shows only weak interaction with importin α. 
The understanding of the NLS and its nuclear transport receptor interaction is mainly 
based on observations using biochemical assays like co-immune precipitation and in vitro 
transport assays. This study was intended to provide corresponding in vivo evidence. By 
expressing fusion proteins of core and fluorescent marker protein, the strength of core 
NLS and the impact of phosphorylation was investigated.  
To analyze the intracellular localization of HBV capsid in human liver cells, firstly the 
entire HBV genome was transfected into HuH-7 cells. The HBV capsid was found to be 
localized predominantly in the nucleus as it is in vivo.  EGFP was chosen as a fluorescent 
marker protein to generate fusion protein with HBV core. The fusion protein was shown to 
form at least dimers but failed to assemble to capsids. This fusion protein was imported 
into the nucleus, redundancy of the HBV core NLS increased the translocation. Moreover 
the replacement of the theoretically weak HBV core NLS by the NLS of the SV40 Tag led 
to a similar transport competence. 
The nuclear import was dependent upon phosphorylation as shown by 
Staurosporine treatment of transfected cells. The different fusion proteins used in these 
assays showed that serine 141 is the key amino acid that has to be phosphorylated. This 
phosphorylation however seems to differ in different cell lines and was apparently affected 
by the growth conditions of the cells. It must be thus concluded that there is a complex 
phosphorylation pattern of the core protein that affects different steps in the viral life cycle 
including nuclear transport. The coordination of these different phosphorylation steps 
remains to be elucidated. 
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6. Zusammenfassung 
 
HBV Core-Partikel sind an einer Reihe wichtiger Funktionen im viralen 
Replikationszyklus beteiligt. Kernimportstudien mit zellulären Proteinen haben gezeigt, 
dass HBV-Kapside, dem klassischen Importweg karyophiler Proteine folgend, an den 
Kernporenkomplex binden. Dieser nukleäre Transport wird durch Importin α und β 
vermittelt. Der Kernimport der Kapside wird durch ein Kernlokalisationssignal, welches in 
der carboxyterminalen Domäne zwischen den Aminosäuren 158 und 168 des Core- 
Proteins lokalisiert ist, erleichtert. Das Kernimportsignal des HBV Core-Proteins enthält im 
Gegensatz zu der Konsensussequenz des NLS keinen Lysinrest, was zu der Annahme 
führte, dass nur eine schwache Interaktion zwischen dem NLS und Importin α 
eingegangen wird. 
Das Verständnis über das Kernlokalisationssignal und die Interaktion mit dessen 
Transportrezeptor basiert hauptsächlich auf Ergebnissen von biochemischen Versuchen, 
wie Koimmunpräzipitationen und in vitro Transportstudien. In dieser Arbeit sollten 
entsprechende in vivo- Beweise gefunden werden. Durch die Expression von 
Fusionsproteinen, bestehend aus dem Core- und einem fluoreszierenden Markerprotein, 
sollten die Stärke des Core-NLS und der Einfluss der Phosphorylierung untersucht 
werden. 
Zur Analyse der intrazellulären Lokalisation von HBV-Kapsiden in menschlichen 
Leberzellen wurden HuH-7 Zellen zunächst mit dem gesamten Genom des Hepatitis B 
Virus transfiziert. Wie auch im lebenden Organismus waren die HBV-Kapside 
überwiegend im Nukleus lokalisiert. Für die Generierung eines HBV-Core-Fusionsproteins 
wurde EGFP als Markerprotein verwendet. Es konnte gezeigt werden, dass dieses 
Fusionsprotein in der Lage ist, Dimere zu bilden, ein Assembly zu Kapsiden jedoch 
ausblieb. Das Fusionsprotein wurde in den Zellkern importiert, wobei die Redundanz der 
HBV-Core NLS die Translokation erhöhte. Darüber hinaus  zeigte der Austausch des 
theoretisch schwachen Core-NLS gegen das Kernlokalisationssignal des SV40 Tag eine 
ähnliche Transportkompetenz. 
Durch die Behandlung von transfizierten Zellen mit Staurosporine konnte gezeigt 
werden, dass der nukleäre Import von der Phosphorylierung abhängig ist. 
Untersuchungen mit unterschiedlichen Fusionsproteinen weisen darauf hin, dass es sich 
bei Serin 141 um eine besondere wichtige Aminosäure handelt, welche phosphoryliert 
werden muss. Diese Phosphorylierung scheint sich in verschiedenen Zelllinien zu 
unterscheiden und offenbar durch die Wachstumsbedingungen der Zellen beeinflusst zu 
werden. Die vorliegenden Ergebnisse lassen den Schluss zu, dass das Core-Protein ein 
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komplexes Phosphorylierungsmuster aufweist, welches im viralen Lebenszyklus 
unterschiedliche Schritte, inklusive nukleärer Transport, beeinflusst. Die Aufklärung der 
Koordination dieser unterschiedlichen Phosphorylierungen bleibt zukünftigen Studien 
vorbehalten.  
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